Research Funding Opportunities
The information on this page is directed to researchers within the Schulich School of Medicine & Dentistry.
In addition to the opportunities below, Schulich researchers can consult Pivot, a comprehensive database of grant information.
Western's Office of Research Development & Services maintains information on Funding and Opportunities.
Archived announcements for 2011, 2010, 2009 and 2008 are available.
May 15, 2012
American Foundation for Suicide Prevention
Six types of grants are awarded for neurobiological, genetic, epidemiological, clinical or psychosocial research on suicide:
- DISTINGUISHED INVESTIGATOR GRANTS (up to $100,000 over two years): awarded to investigators at the level of associate professor or higher with an established record of research and publication on suicide.
- STANDARD RESEARCH GRANTS (up to $75,000 over two years): awarded to individual investigators at any level.
- LINKED STANDARD RESEARCH GRANTS (up to $225,000 over two years): awarded to investigators at any level performing research involving three or more unique sites.
- YOUNG INVESTIGATOR AWARDS (up to $85,000 over two years): awarded to investigators at the level of assistant professor or lower. In addition to a maximum of $75,000 for the investigator’s research, these grants provide an additional $10,000 ($5,000 per year) for an established suicide researcher who will mentor the Young Investigator. AFSP can assist in matching mentors with mentees.
- POSTDOCTORAL RESEARCH FELLOWSHIPS (up to $100,000 over two years): awarded to investigators who have received a Ph.D., M.D., or other doctoral degree within the preceding six years and have not had more than three years of fellowship support. Fellows receive a progressive stipend of $42,000 for the first year and $46,000 for the second year, with an institutional allowance of $6,000 per year.
- PILOT GRANTS (up to $30,000 over one or two years): awarded to investigators at any level. These grants provide seed money for new projects with the potential to lead to subsequent, larger investigations and are typically feasibility rather than hypothesis-driven studies.
Deadline: Nov 15, 2012
For more info: http://www.afsp.org/index.cfm?page_id=0535FDA2-FA7D-AAE8-D7A9A6BCFFE3574B
Canada-Latin America and the Caribbean Research Exchanges
The Canada-Latin America and the Caribbean Research Exchange Grants program (LACREG) is designed to strengthen international partnerships and consolidate emerging networks among academic researchers from Canada and Latin America and the Caribbean. Its purpose is to support small collaborative research activities which will contribute to the creation, dissemination and sustained application of knowledge in the development process in at least one area of the International Development Research Centre’s thematic priority.
Eligibility: Applicants from Canada and the following Latin American and Caribbean countries: Argentina, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Trinidad and Tobago, and Venezuela.
Amount: Support through this program will be cost-shared on a 2:1 ratio by the program and the partner institutions, respectively. The maximum value of each grant will be $15,000 Cdn.
Deadline: June 29, 2012
For more info: http://www.aucc.ca/programs-services/international-programs/canada-latin-america-and-the-caribbean-research-exchange-grants-lacreg/
Citizens United for Research in Epilepsy - 2012 Directed Research Initiative: Advancing Understanding of Infantile Spasms Award
CURE, Citizens United for Research in Epilepsy promotes collaborative research that advances the search for a cure for epilepsy, and addresses the goal of “no seizures, no side effects.” For this initiative, CURE seeks to fund investigators focused on finding a cure for infantile spasms. Both basic scientists and clinicians are encouraged to apply.
Deadline for letter of intent: June 27, 2012
For more info: http://www.cureepilepsy.org/research/grant_is.asp
Research Grant Applications are being accepted for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders. Grant applications by new investigators are strongly encouraged. Grant applications will be evaluated on the basis of science, feasibility, and relevance. Listed below are some areas of interest; however, all relevant grant applications are encouraged and will be considered.
- Biology of dendritic cells, macrophages and/or lymphocytes in the pathogenesis of histiocytic disorders
- CNS pathology in histiocytic disorders
- Cytokine production in histiocytic disorders
- Focused studies on the more rare histiocytic disorders including Erdheim-Chester disease, Juvenile xanthogranuloma and Rosai-Dorfman disease
- Histiocytic disorders in adults
- Immune function studies in histiocytic disorders
- Marker studies for histiocytic disorders
- Mechanism of dendritic cell homing
- Mechanisms of disease pathogenesis in histiocytic disorders
- Neuropsychiatric consequences of histiocytic disorders
- Studies of surface antigen profile of LCH lesional cells
Amount: up to $50,000 USD
Deadline: July 31, 2012
For more info: http://www.histio.org/page.aspx?pid=870
International Myeloma Foundation - Brian D. Novis Senior Research Grants
These awards go to doctors/researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undermined significance), as well as immunoglobulin derived amyloidosis. These awards are targeted to established investigators with a track record in myeloma or related research, and are designed for projects which represent a different focus, direction or area of research from those in which they are currently funded. In most cases, these awards will be for pilot projects to obtain sufficient funding for larger applications from NIH or similar larger funding agencies.
Amount: $80,000. Institutional overhead must not exceed $8,000 (10 percent of the total award amount)
Deadline: Aug 01, 2012
For more info: http://myeloma.org/IndexPage.action?tabId=4&menuId=8&indexPageId=19&parentMenuItemId=8&categoryId=0
Juvenile Diabetes Research Fund - Innovative Grants
Supports proposals for highly innovative research with potential significant impact on accelerating the mission of JDRF. The innovative research should have the potential for a change in the current paradigm or conventional wisdom or to lead to a seminal discovery or to be groundbreaking.
Amount: maximum of 110,000 USD /year for one year, including up to 10% for indirect costs
Deadline: July 16, 2012
For more info: http://www.jdrf.org/index.cfm?page_id=114027
LAM Foundation research awards include Post Doctoral Fellowships, Established Investigator Awards, and Pilot Project Awards.
Examples of competitive LAM proposals include those that focus on the genetic regulation of smooth muscle growth or the development of a smooth muscle cell line that is representative of the LAM lesion. Mechanistic, hypotheses-driven approaches of all types are welcomed. Formalin-fixed LAM tissues, dispersed LAM lung cells, genetic probes and other reagents are available.
Deadline for letters of intent: July 30, 2012
For more info: http://www.thelamfoundation.org/research/apply-for-lam-funding
NSERC - Idea to Innovation (I2I) Program
The objective of the Idea to Innovation (I2I) program is to accelerate the pre-competitive development of promising technology originating from the university sector and promote its transfer to a new or established Canadian company. The program provides funding to college and university faculty members to support research and development projects with recognized technology transfer potential. This is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.
Eligible research and development activities include (but are not limited to) the following:
- Refining and implementing designs
- Verifying application
- Conducting field studies
- Preparing demonstrations
- Building engineering prototypes
- Performing beta trials
Eligible technology transfer activities include (but are not limited to) the following:
- Market studies
- Consulting fees (for business plan, market survey)
- Patenting expenses (see limitations in program guidelines)
- Expenses associated with creating a partnership (travel)
Deadlines: Jul 03, 2012; Oct 01, 2012
For more info: http://www.nserc-crsng.gc.ca/Professors-Professeurs/RPP-PP/I2I-INNOV_eng.asp
Spinal Research - Strategy Awards
Spinal Research is an UK charity funding medical research around the world to develop reliable treatments for paralysis caused by a broken back or neck.
Strategy grants form the mainstay of the sponsor's basic science programme and are normally awarded following an internationally-advertised competitive call for proposals based on themes identified by the Scientific Advisory Committee.
Research proposals are called for that address or help identify clinically relevant effective treatments in either (i) severe or (ii) chronic spinal cord injuries. Applicants should note that proposals that can show they address both criteria are especially welcomed.
Preference will be given to applications that involve studies in the adult mammalian spinal cord.
Deadline for letter of intent: Jun 08, 2012
For more info: http://www.spinal-research.org/research-matters/grants-awards/applying-for-a-grant/types-of-grant/
Translational Breast Cancer Research Traineeship program
The 2012-2013 Translational Breast Cancer Research Traineeship program is now open for applications.
The purpose of the Program is to encourage and support translational breast cancer research by providing funding for graduate students and postdoctoral scholars. This program is made possible by a major donation from the Breast Cancer Society of Canada to the Translational Breast Cancer Research Unit at the London Regional Cancer Program (LRCP), as well as donations from other groups interested in supporting translational breast cancer research.
Trainees working under the supervision of any Western faculty member who is actively engaged in breast cancer research are invited to apply. Proposals should have a strong focus on translational breast cancer research.
Deadline for applications: June 29, 2012
Application form and information can be obtained at: http://www.lhsc.on.ca/Research_Training/LRCP/Research_Groups/TranslationalBreastCancerResearch.htm
For more info: contact Dr. Ann Chambers, 519-685-8652 or (ext. 58652), ann.chambers@lhsc.on.ca or Joanne Gribbon, 519-685-8600 ext. 55769, joanne.gribbon@lhsc.on.ca
U.S.Department of Defense Autism Research Program
Supports the development of innovative, high-impact ideas that advance the understanding of autism spectrum disorders (ASD) and lead to improved outcomes.
Funding mechanisms include:
• Idea Development Award
• Pilot Award
Deadline for pre-applications: June 20, 2012
For more info: http://cdmrp.army.mil/funding/arp.shtml
U.S. Department of Defense Peer Reviewed Cancer Research Program
The Department of Defense (DoD) Peer Reviewed Cancer Research Program (PRCRP) focuses research on cancers not addressed in breast, prostate, lung (excluding mesothelioma), and ovarian cancer research programs currently executed by the DoD U.S. Army Medical Research and Materiel Command (USAMRMC). The funds provided are directed to be used to conduct research for the following topic areas:
• Blood cancers
• Colorectal cancer
• Genetic cancer research
• Kidney cancer
• Listeria vaccine for cancer
• Melanoma and other skin cancers
• Mesothelioma
• Pancreatic cancer
• Pediatric brain tumors
Deadline for pre-applications: June 19, 2012
For more info: http://cdmrp.army.mil/funding/prcrp.shtml
April 30, 2012
2013 Rosalind Franklin Young Investigator Award
To honor the ground-breaking contributions of Dr. Rosalind Franklin in genetics research and to inspire and support new generations of women in the field, the Peter and Patricia Gruber Foundation will fund two career development research awards of $75,000 each to be given over three years ($25,000 per year) to two female geneticists from anywhere in the world, who are in their first three years of an independent faculty-level position in any area of genetics. One award will fund genetics research in human and non-human mammals and the other will fund genetics research in model organisms. Young female geneticists from any country worldwide are welcome to apply. The award may be used for any purpose that advances the genetics research of the recipients except for salary support of the recipients themselves.
Deadline: June 8, 2012
For more info: http://www.ashg.org/awards/2012/rosalind_franklin12.html
Association for Frontotemporal Degeneration - Research Grants - Accelerating DRUG DISCOVERY for Frontotemporal Degeneration
Research investigating the pathologic mechanisms of neurodegeneration in frontotemporal degeneration (FTD) and related disorders is advancing, creating new potential targets for drug discovery. The Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) seek to accelerate and support drug discovery for FTD and related dementias through this Request for Proposals (RFP).
Priority areas for this program include:
- Target validation studies
- Development and testing of novel high throughput screening assays
- Medicinal chemistry on lead compounds
- Identification and in vitro testing of potentially disease modifying lead compounds
- ADME, toxicology, pharmacokinetics, pharmacodynamics on lead compounds
- Testing of lead compounds in a relevant animal model for preclinical proof of concept
- Development of biomarkers to accelerate drug development and early diagnosis
- Innovative pilot clinical trials
Applicants should note that this funding will not support applications for basic research.
Amount: up to $150,000
Deadline for letter of intent: Sep 06, 2012
For more info: http://www.theaftd.org/research/aftd-research-initiatives/current-rfps
Benign Essential Blepharospasm Research Foundation, Inc.
The mission of the BEBRF is to undertake, promote, develop, and carry on the search for the cause and a cure for benign essential blepharospasm and other related disorders and infirmities of the facial musculature. Funds are available for support of research directly related to blepharospasm or Meige's Syndrome, both forms of cranial dystonia. Research proposals must relate specifically to benign essential blepharospasm and Meige to include new treatments, pathophysiology and genetics, photophobia, and dry eye.
Amount: up to $150,000
Deadline: Aug 31, 2012
For more info: http://www.blepharospasm.org/res-prop.html
China - Canada Joint Health Research Initiative
The program, established in 2005, is jointly managed and funded by CIHR and the National Natural Science Foundation of China (NSFC). Its aim is to promote the development of Canadian-Chinese scientific co-operation between universities, hospitals, research institutes or affiliated research organizations in Canada and China through the support of collaborative research grants.
Deadline: May 15, 2012
CIHR Catalyst Grant: Health Services and Systems for an Aging Population
The specific objectives of this funding opportunity are to:
- support innovative ideas and projects aligned with the goals, objectives and principles of the Institute of Aging (IA)'s Health Services and Systems for an Aging Population (HSSAP) initiative;
- support original, high quality projects which have the potential to generate high impact results and/or innovative research proposals, research tools, techniques, or methodologies;
- encourage researchers from other fields to consider research questions related to Health Services and Systems for an Aging Population.
Amount: maximum of $ 100,000 for up to one year
Deadline for Registration: June 15, 2012
CIHR Evidence-Informed Healthcare Renewal - Healthcare Renewal Policy Analysis grants
CIHR has launched an exciting new funding opportunity called Healthcare Renewal Policy Analysis. This is a joint program developed by CIHR IHSPR and the Knowledge Translation Branch as part of CIHR's Roadmap Signature Initiative in Evidence-Informed Healthcare Renewal (EIHR).
Healthcare Renewal Policy Analysis grants depend on meaningful partnerships between researchers and senior-level policy makers who work directly within the health sector in federal, provincial or territorial government departments, regional health authorities, or LHINs as well as those who work in other sectors (e.g., education, social services, industry) that develop policy with population-level health impacts.
These grants will support the generation of high-quality policy analyses that identify evidence-informed policy options for healthcare renewal in Canada in the EIHR priority areas of healthcare financing and funding, health system sustainability, and governance and accountability. Innovation in these areas will require contributions from a wide range of disciplines and would greatly benefit from contributions from economics, political science, sociology, philosophy, law, and other relevant fields.
Amount: up to $150,000 over one year
Deadline: September 19, 2012
Dairy Farmers of Canada - Dairy Research Cluster 2
In preparation for the next Dairy Cluster proposal, Dairy Farmers of Canada (DFC) is launching a “Call for Applications” that would contribute to its vision for the second phase of the Dairy Cluster activities: “Dairy Research for a Healthy World”. DFC invites all Canadian scientists to respond to this call.
The research priority areas fall under two main streams of the Dairy Research Cluster 2: Sustainable Milk Production and Human Nutrition and Health. In all cases, proposed activities must clearly contribute to at least one of the priorities outlined by DFC.
Deadline for Letter of Intent: June 1, 2012
For more info: https://www.dairyresearch.ca/dairy-research-cluster.php
The fund is accepting applications for research on all aspects of Fanconi anemia.
Deadline: Continuous
For more info: http://www.fanconi.org/index.php/research/grant_applications
Bill & Melinda Gates Foundation - Grand Challenges Explorations Round 9
Grand Challenges Explorations (GCE) supports hundreds of early-stage research projects – including many ideas that have never before been tested -- and scientists from a wide range of disciplines and regions. The Explorations initiative funds innovative ideas that could lead to new vaccines, diagnostics, drugs, and other technologies targeting diseases that claim millions of lives every year.
Deadline: May 15, 2012
For more info: http://www.grandchallenges.org/Explorations/Pages/ApplicationInstructions.aspx
National Brain Tumor Society seeks Letters of Intent for transformative or catalytic scientific research projects that will significantly move the field forward toward effective brain tumor therapies. Innovation Grants respond to the brain tumor community's need for a rapid review process to support highly innovative research projects including those that are "out-of-the-box."
Innovation Grants will fund projects that highlight innovative research strategies and will support the development of novel brain tumor therapies for adult and/or pediatric brain tumor patients. No set amount of preliminary data is required and research may fall within any stage of the research and development continuum.
Amount: $150,000 per year for two years
Deadline for letter of intent: continuous
For more info: http://www.braintumor.org/research/funding-opportunities/
National Organization for Rare Disorders
NORD is offering the following funding opportunities for 2012 through its international clinical research program. The NORD Research Grant Program provides seed-money grants to academic scientists for scientific and/or clinical research. The hope is that these studies will ultimately lead to new diagnostics, treatments, and/or cures for rare diseases. NORD’s program provides grants for the study of diseases for which there are few other sources of funding.
- APS Type 1, aka Autoimmune Polyglandular Syndrome, Type 1
- Alveolar Capillary Dysplasia
- Congenital Hyperinsulinism (HI) in Neonates and/or Children
- Primary Immune Thrombocytopenia in Adults
- Pseudomyxoma Peritonei (PMP)
Deadline: May 4, 2012
For more info: http://www.rarediseases.org/medical-professionals/research-grants/rfps
Progeria Research Foundation Research Grants
Proposals will be accepted in three categories of differing type, funding levels and length of time:
1.Innovator Awards: 2-year awards of up to $75,000 per year. The aim of the Innovator Award is to allow an investigator to embark on new lines of investigation, and to produce enough preliminary data to be competitive for longer-term funding by NIH and/or other agencies.
2.Established Investigator Awards: for senior investigators established either in the field of Progeria or a field that can be directly applied to Progeria. These grants are for up to 3 years and up to $100,000 per year.
3.Specialty Awards: for smaller, more technology-driven projects, e.g., sequencing, screening potential drugs, obtaining cell lines (including IPSCs,) and preparation of antibodies. Funding amounts and lengths are flexible.
Deadline: May 4, 2012
For more info: http://www.progeriaresearch.org/research_funding_opportunities.html
Terry Fox New Frontiers Program in Cancer - Team Grant
The objective of the Terry Fox New Frontiers Program Project (Terry Fox New Frontiers) Grant at CIHR program is to support Canadian research teams to explore new frontiers in cancer research (i.e., breakthrough and transformative biomedical, clinical, and translational research providing information that may form the basis for innovative cancer prevention, diagnosis and/or treatment). The program will strengthen Canadian cancer research by supporting teams of talented and experienced researchers conducting high-quality research.
The Terry Fox New Frontiers grant is designed specifically to support high-risk projects of large potential impact, where the environment will maximize the chances of success. The funding program emphasis is on the production of new knowledge, and the translation of research findings into improvements in the health of Canadians. These results will be realized more rapidly and more efficiently through the collaborative team approach support by Terry Fox New Frontiers Program grants than if the component projects were to be funded as a series of separate operating grants.
The research program must comprise of at least three distinct sub-projects. The sub-projects that make up the research program must be able to stand as independently fundable research projects, but at the same time, must contribute substantially to the primary research goal.
The projects in the program must represent scientific input from all principal applicants contributing substantially to the primary research goal. This competition is open to applications that address issues related to the cause of cancer, cancer prevention and diagnosis, cancer care and the cancer care system.
Deadline for letter of intent: Jul 03, 2012
U.S. Dept. of Defense Lung Cancer Research Program
Translational Research Partnership Award - Supports partnerships between clinicians and laboratory scientists that accelerate the movement of promising ideas in lung cancer into clinical applications. One investigator must be a laboratory scientist, and the other must be a clinician. Preliminary data required, but may be from outside of lung cancer.
LCRP Idea Development Award mechanism is being offered for the first time in FY12. The award is designed to promote new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This mechanism supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. To be considered for funding, applications must address at least one of the seven areas of emphasis listed below:
1. Identification or development of non-invasive or minimally invasive tools to improve detection of the initial stages of lung cancer.
2. Identification, development, and/or building upon already existing tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging biomarkers, genetics/genomics/ proteomics/metabolomics, and assessment of risk factors.
3. Understanding the molecular mechanisms of progression to clinically significant lung cancer.
4. Understanding the molecular mechanisms that lead to various subtypes of lung cancer.
5. Identification of innovative strategies for prevention and treatment of early lung cancer.
6. Understanding predictive and prognostic markers to identify responders and nonresponders
7. Understanding acquired resistance to treatment.
Deadline for pre-applications: May 30, 2012
For more info: http://cdmrp.army.mil/funding/lcrp.shtml
Vasculitis Foundation Research Grant Program
The goals of the program are to improve the quality of life for patients with vasculitis and ultimately find the cause/s and cure for vasculitis.
The purpose of the program is to provide one or two year seed grants to support pilot studies in researching the:
- etiology
- epidemiology
- diagnosis
- treatment, including approaches that would prevent complications, and development of coping skills for living with this disease
Deadline: Aug 13, 2012
For more info: http://www.vasculitisfoundation.org/research
Wellcome Trust - Pathfinder Awards
The Pathfinder Awards are intended to facilitate funding applications that would be considered too early for support under the Wellcome Trust's other translational funding schemes. The focus of the scheme is orphan and neglected diseases, where no current therapy exists or where the proposed product will be superior to the existing options. Projects covering any aspect of product development for neglected and orphan diseases could be considered.
The Pathfinder Awards are intended to kick-start pilot research projects that have significant potential to help develop innovative new products in these disease areas. The funding will help academic teams, or teams from not-for-profit groups, to build on existing partnerships or establish partnerships with a company that has specialist knowledge and access to technologies to facilitate the development of a specific product. By the end of the Pathfinder Award, the innovation should be a credible asset ready to be further developed by the company and/or be competitive for one of the Wellcome Trust's existing translational awards schemes, through which substantial resources may be sought.
There are no geographical restrictions. Applications are welcome from appropriate public sector-company partnerships in a global setting.
Amount: The project duration will be a maximum of 18 months from the agreed commencement date. The Wellcome Trust contribution to the partnership will be capped at £100 000. Evidence of a matching funding contribution from the company partner will be expected.
Deadline: Jun 06, 2012
Note: There will be four rolling deadlines in a 12-month period, subject to available budget in the current financial year.
For more info: http://www.wellcome.ac.uk/Funding/Technology-transfer/Awards/Pathfinder-Awards/index.htm
April 15, 2012
Alliance for Lupus Research Target Identification in Lupus Grants
The ALR funds research that will accelerate the development of new treatments for lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies in genetics, immunology, cell biology and molecular biology to identify and characterize molecular systems must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus.
Amount: up to $200,000/year for a maximum of three years
Deadline for Letter of Intent: July 10, 2012
For more info: http://www.lupusresearch.org/research/grants.html
American Academy of Implant Dentistry
These grants is intended to provide limited support for meritorious dental implant research projects which include, but are not limited to, the following purposes:
1. To conduct research which determines the feasibility of a larger research project. This may be described as the conduct of pilot studies of venture research.
2. To develop and test new techniques and procedures.
3. To carry out a small clinical or animal research project.
4. To analyze existing data.
Amount: $25,000
Deadline: Aug 01, 2012
For more info: http://www.aaid.com/research_foundation/Grants_and_Activities.html
The Brain Aneurysm Foundation invites applications for basic scientific research directed at early detection, improved treatment modalities, and technological advances that will ultimately improve outcomes for patients with brain aneurysms. Any project with the potential to advance basic scientific and translational brain aneurysm research will be considered. Clinical projects will not be funded.
Amount: $25,000
Deadline: April 25, 2012
For more info: http://www.bafound.org/applying-research-grant
Canadian Celiac Association - J.A. Campbell Research Grant
The Canadian Celiac Association offers a grant for research projects in Canada of a scientific, applied science, and/or medical nature relevant to Celiac Disease, Dermatitis Herpetiformis, and/or non-celiac Gluten Sensitivity, or the socio-economic implications of living with these conditions.
This award is to encourage research and further the understanding of the full range of implications of Celiac Disease (gluten-induced enteropathy), Dermatitis Herpetiformis, and/or non-celiac Gluten Sensitivity. While open to all types of relevant research, the focus in 2012 will be studies that further the understanding of gluten sensitivity or the socio-economic factors impacting how people live with their condition.
Amount: up to $25,000
Deadline: Apr 30, 2012
For more info: http://www.celiac.ca/index.php/about-the-cca/research-awards/
Childhood Apraxia of Speech Association of North America
CASANA initiated the Apraxia Treatment Research Fund in order to fund pilot research projects aimed at better understanding effective treatment options for children with apraxia of speech.
This year, CASANA has decided to expand the potential projects to include those that address clinical questions in either diagnostic criteria or treatment. They are issuing a Request for Applications for Childhood Apraxia of Speech Clinical Research proposals.
Amount: $25,000
Deadline: May 01, 2012
Cystic Fibrosis Foundation Pilot and Feasibility Awards
These grants are for developing and testing new hypotheses and/or new methods, and to support promising new investigators as they establish themselves in research areas relevant to CF. Proposed work must be hypothesis driven and must reflect innovative approaches to critical questions in CF research.
Amount: Up to $40,000 per year (plus 8% indirects) for two years
Deadline for letters of intent: April 25, 2012
For more info: http://www.cff.org/research/ForResearchers/FundingOpportunities/ResearchGrants/
Cystic Fibrosis Foundation Research Grants
This grant mechanism is intended to encourage the development of new information that contributes to the understanding of the basic etiology and pathogenesis of CF. Funding priority will be placed on those projects proposing to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat it. All proposals must be hypothesis driven, and sufficient preliminary data must be provided to justify CFF support. Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health (NIH).
Amount: $90,000 per year (plus 8% indirects) for a period of two years
Deadline for letters of intent: April 25, 2012
For more info: http://www.cff.org/research/ForResearchers/FundingOpportunities/ResearchGrants/
Glaucoma Foundation Grant-in-Aid
The Glaucoma Foundation offers grants to doctors and scientists striving to improve the lives of glaucoma patients through research. TGF's three areas of particular focus for grant-in-aid funding are Optic Nerve Rescue and Restoration, Molecular Genetics, and Nanotechnology.
Amount: Initial grant funding for a one-year period is for up to $40,000; a grantee is permitted to apply for a grant renewal of up to $50,000
Deadline: Sept 01, 2012
For more info: http://www.glaucomafoundation.org/Grant_Application.htm
William T. Grant Foundation - Scholars Program
The Scholars Program supports the professional development of early-career researchers in the social, behavioral, and health sciences. The goal is to help Scholars tackle important questions that will advance theory, policy, and practice for youth and to do so with an expanded array of expertise that includes different methods, disciplinary perspectives, and content knowledge. Potential Scholars should have a promising track record of conducting high-quality research, but want to pursue a qualitative shift in their trajectory as researchers.
The Foundation supports research to understand and improve the everyday settings of youth ages 8 to 25 in the United States. The Foundation funds studies that enhance our understanding of: (1) how settings work, how they affect youth development, and how they can be improved; and (2) when, how, and under what conditions research evidence is used in policy and practice that affect youth, and how its use can be improved.
Applicants must have received their terminal degree within seven years of submitting their application.
Applicants outside the United States are eligible. As with U.S. applicants, they must pursue research that has compelling policy or practice implications for the settings of youth ages 8 to 25 in the United States.
Deadline: Jul 03, 2012
For more info: http://www.wtgrantfoundation.org/funding_opportunities/fellowships/william_t__grant_scholars/william_t_grant_scholars
The Kennedy’s Disease Association is planning to fund one or more research grants in the fall of 2012 to further the understanding of the pathological mechanisms of Kennedy’s Disease. Applications from junior investigators and from senior post-doctoral fellows are encouraged.
Amount: up to $25,000
Deadline: Jun 22, 2012
For more info: http://www.kennedysdisease.org/promote-research/research-grants
The Mesothelioma Applied Research Foundation announces the availability of its 2012 round of mesothelioma research grant funding. Continuing its efforts to stimulate translational research for the treatment of malignant mesothelioma, the Meso Foundation is again soliciting applications for funding of innovative projects that address issues for the treatment of the disease. Eligible projects may relate to benchwork, translational or clinical research and may be conducted through any not-for-profit academic, medical or research institution, in the U.S. or abroad.
Amount: $50,000/year for up to 2 years
Deadline: July 6, 2012
For more info: http://www.curemeso.org/site/c.kkLUJ7MPKtH/b.4097447/k.E6A3/Mesothelioma_Research_Grants__Call_for_Applications.htm
Michael J. Fox Foundation for Parkinson's Research Target Validation 2012--An Edmond J. Safra Core Program for PD Research
To promote validation of novel targets, funding from our Target Validation program supports work demonstrating whether modulation of a novel biological target has impact in a PD-relevant animal model – an essential early step to the development of potential targeted therapies.
Deadline for Pre-Proposals: May 31, 2012
For more info: http://www.michaeljfox.org/research_openFundingPrograms_program.cfm?ID=45
Michael J. Fox Foundation for Parkinson’s Research Therapeutics Development Initiative
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces the launch of the Therapeutics Development Initiative – Spring 2012, a funding mechanism to support and stimulate preclinical Parkinson’s disease research at for-profit institutions. Part of the annual Pipeline Programs, this funding program seeks to support preclinical development of Parkinson’s disease therapies which have the potential for fundamentally altering disease course and/or improving treatment of symptoms above and beyond current standards of care. Proposals must focus on key and critical preclinical studies necessary for developing, optimizing and evaluating therapeutic strategies that, if successful, can move into human testing.
Deadline for Pre-Proposals: May 31, 2012
For more info: http://www.michaeljfox.org/research_openFundingPrograms_program.cfm?ID=46
The Myositis Association (TMA) places a high priority on research into the cause, prevention, detection, treatment and cure of Myositis.
Deadline for Letter of Intent: June 8, 2012
For more info: https://www3447.ssldomain.com/myositis/template/page.cfm?id=462
Applications are being requested for a one- or two-year grant for basic or clinical research. The grant program is designed to provide financial support for investigators studying any or all disciplines involved in Marfan syndrome and related disorders. Special areas of interest include basic research, translational studies and clinical studies in cardiovascular, genetic, orthopedic and ophthalmologic issues utilizing synergistic collaborations, integration of novel theories from non-traditional researchers into established paradigms, novel animal model systems; innovation and the distillation of knowledge into practical new therapies.
Deadline: Jun 11, 2012
For more info: http://www.marfan.org/marfan/2293/Research-Grants
March 31, 2012
American Orthotic and Prosthetic Association
The American Orthotic & Prosthetic Association is proud to announce a Request for Pilot Grant Proposals in five potential areas of Orthotic and Prosthetic (O&P) research. Areas for submission are:
a. Microprocessor Knee – Stumble Recovery Benefit for Non-Variable Cadence Ambulators, and Does Restricted Access for K-1 and K-2 to Hydraulic Controls Adversely Impact Patient Safety?
b. Validity of Energy Storing Feet – AK/BK , Clinical Appropriateness and Efficacy of Dynamic Response Feet for K-3 Patients, and Defining Appropriate Levels of Variable Cadence
c. TLSO, Reduction of Fall and/or Injury Related to Different Types of Spinal Devices Post Surgery
d Socket Interface: Methods for Measuring Proper Socket Fit and Alignment.
e. Vacuum-Assisted Socket Suspension Systems
f. Open Topics – Beyond the Above Priorities, Top Quality Clinical O&P Research Topics Considered
Amount: up to $15,000 for one year
Deadline: April 30, 2012
For more info: http://www.aopanet.org/RFP_2012_Small_Grants_Announcement.pdf
The program financially supports scientific studies investigating tinnitus. Studies must be directly concerned with tinnitus and contribute to ATA's goal of finding a cure.
Amount: up to $50,000 per year for up to three years, for a potential maximum of $150,000
Deadline: Jun 30, 2012
For more info: http://www.ata.org/research/grant-program
Batten Disease Support and Research Association
The BDSRA has announced that funds are available to conduct research directly relevant to the development of treatment of lysososomal storage and neurodegenerative diseases, specifically, Neuronal Ceroid Lipofuscinoses (NCL). Research is needed across a broad spectrum addressing the underlying mechanisms of neural dysfunction and degeneration in each form of NCL from dysfunctional soluble lysosomal enzymes (PPT1, TPP1, CTSD), transmembrane proteins (CLN3, CLN6, MFSD8, CLN8) and other proteins implicated in lysosome function and trafficking (CLN5). Proposals will be considered for all forms of NCL, with emphasis on CLN1, CLN2, and CLN3.
Deadline: May 25, 2012
For more info: http://www.bdsra.org/research.html
Canadian Epigenetics, Environment and Health Research Consortium Team Grant
One of the main goals of the CEEHRC - one of CIHR's Roadmap Signature Initiatives - is to link innovative research in epigenetics to human health and disease. Toward this end, CEEHRC recognizes the importance of all levels of research in epigenetics, from individual cells to whole populations. Key to all approaches is a focus on collaborative research – namely, integrating different methodologies and disciplines aligned along key health needs. This Team grant funding opportunity encourages the translation of research in epigenetics to health benefit, recognizing that this will ultimately require the participation of researchers across the full spectrum of health research, including biomedical, clinical, health systems and health policy, and population and public health. The key focus for this funding opportunity is the exploration of gene-environment interactions where epigenetics may play role. This program will support collaborative research teams that have the capability to transform epigenetics research, enhance our understanding of gene-environment interactions, address major health research questions (including health services/policy/economic/ethical, legal or social issues), and foster the application of knowledge gained to the clinic and/or to populations.
Amount: The total amount available for this funding opportunity is $9,000,000. The maximum amount for a Team is $300,000 per year for up to five years.
Deadline for Letter of Intent: May 31, 2012
For more info: www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=1505
CIHR/NSERC Collaborative Health Research Projects (CHRP)
The Collaborative Health Research Projects (CHRP) program is a joint initiative between NSERC and CIHR. The CHRP program supports innovative interdisciplinary collaborative research projects requiring participation from the natural sciences or engineering community together with the health sciences community. Proposed research projects must have a strong focus on knowledge translation (KT) and lead to health and economic benefits for Canadians, more effective health services and products, and/or a strengthened health care system. Funding for CHRP projects can be for up to three years for defined projects with clear milestones and decision points.
Deadline for letters of intent: May 15, 2012
Crohn's and Colitis Foundation of America Senior Research Awards
The objective of these awards is to provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources, such as the National Institute of Health (NIH). Proposals must be relevant to inflammatory bowel disease (Crohn's Disease or ulcerative colitis).
Deadlines for letter of intent: May 1, 2012; Nov 01, 2012
For more info: http://www.ccfa.org/ccfaprof/sra/index.html
Cystic Fibrosis Foundation - Clinical Research Awards
These awards offer support to clinical research projects directly related to Cystic Fibrosis (CF) treatment and care. Projects may address diagnostic or therapeutic methods related to CF or the pathophysiology of CF. Applicants must demonstrate access to a sufficient number of CF patients from accredited CF Foundation care centers and appropriate controls.
Deadlines for letters of intent: Jun 01, 2012; Dec 01, 2012
For more info: http://www.cff.org/research/ForResearchers/FundingOpportunities/ClinicalResearchAwards/
Request for Proposals: Development of a Longer-Acting Injectable Contraceptive
With funding from the Bill & Melinda Gates Foundation, FHI 360 has launched a project to support early testing of innovative approaches to developing a longer-acting injectable contraceptive. This project is the first step toward bringing a game-changing injectable contraceptive to market, thereby expanding contraceptive access and choice for women around the world.
As part of this effort, FHI 360 announces a funding opportunity for proof-of-concept testing of candidates or approaches that have the potential to be developed into a longer-acting injectable. Proposals may include research that supports the development of new drugs, new formulations of existing drugs, or new methods of delivery and routes of administration for existing drugs. Proof-of-concept testing may include a wide variety of research activities such as laboratory testing, formulation development, and non-clinical or clinical pharmacokinetic/pharmacodynamics studies.
Deadline for Submitting Concept Papers (Stage 1): April 30, 2012
For more info: http://www.fhi360.org/en/Research/res_longeractinginjectables.htm
Education and Research Foundation for the Society of Nuclear Medicine. - 2012 Mitzi & William Blahd, MD Pilot Research Grant
The pilot research grant is designed to help a basic or clinical scientist in the early stages of their career conduct research that may lead to further funding. Applicants must be no more than five years post nuclear medicine/molecular imaging training.
Amount: $25,000
Deadline: Nov 5, 2012
For more info: http://interactive.snm.org/index.cfm?PageID=1083
Juvenile Diabetes Research Foundation - High Priority, Short Term Bridge Awards
Supports research grant applications that address a high priority research area for JDRF, but failed to receive funding (but scored within 10% of the funding payline for a review cycle of a research funding agency up to a year prior to the request to JDRF). Helps investigators generate additional supporting data for an amended, competitive application.
Amount: up to USD 55,000
Deadlines for Full Application: April 2, 2012
For more info: http://www.jdrf.org/index.cfm?page_id=114026
Musculoskeletal Transplant Foundation
There are three categories of Peer Reviewed Grants:
- Junior Investigator Grants: This is a one year award for any Ph.D. or M.D. who is post-graduate work or residency and who has never obtained an award from a foundation or a federal agency. The award is for one year and up to $100,000. Indirect expensese are limited to 20%.
- Established Investigator Grants (New): This is a multi-year program for any researcher who has previously been funded by a foundation or a federal agency and has published in a peer-reviewed journal as a Principal investigator. Each award is for up to three years, and up to $100,000/year. Indirect costs are limited to 20%.
- Dermal Tissue Grants: This is a one year award of up to $100,000 for any researcher interested specifically in dermal allograft tissue transplantation. The emphasis is on research involving dermal allografts, transplant science, and the biologic reconstruction of tissues using grafts derived from dermal tissues. Indirect costs are limited to 20%.
For more info: http://www.mtf.org/research_grant_programs.html
The NFXF supports a broad range of research endeavors that will lead to better understanding, recognition, treatment and an eventual cure of children and adults with a FXD, including fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome (FXTAS), and fragile X-associated ovarian insufficiency (FXPOI).
Translational research projects focus on bringing discoveries made about the nature, causes, and consequences of Fragile X-associated Disorders into the realm of therapeutics and interventions designed to treat the symptoms or underlying deficits of those disorders.
Examples of appropriate projects include investigations of the effects of drugs on people with the disorders or in animal models, studies of educational or psychosocial interventions focused on reducing symptoms or optimizing outcomes of affected people, and studies refining or developing measures that can be used to evaluate the outcomes of therapeutics and interventions.
Amount: maximum of $100,000
Deadline: Apr 30, 2012
For more info: http://www.fragilex.org/research/funding-opportunities/
Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Research Dream Team Call for Ideas
We invite submission of ideas for translational cancer research projects that would address laboratory and clinical efforts that will lead to the immunological treatment, control, and prevention of cancer and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators.
These projects may include identification of inflammatory/immune pathways involved in cancer initiation, progression, dissemination, and responsiveness to therapy and their targeting by therapeutic approaches such as vaccines, antibodies, adoptive cell transfer, cytokines, and other molecularly targeted therapeutics. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.
Please note that in this call for ideas the AACR and CRI are not accepting research proposals for grant funding. Rather, the AACR and CRI are inviting ideas to be submitted in a Letter of Intent for the SU2C-CRI Cancer Immunology Translational Research Dream Team Grant. A subset of those ideas will be selected to submit full research proposals for further consideration. SU2C-CRI Cancer Immunology Translational Research Dream Team will be awarded up to $6 million over the three-year term of the grant.
Deadline for letters of intent: April 9, 2012
Terry Fox New Investigators Award
The Terry Fox Research Institute is pleased to announce a new competition for Terry Fox New Investigators. The purpose of this award is to provide outstanding young researchers with support as they develop their career as independent research scientists or clinician scientists and to undertake high-quality research into cancer in close collaboration with established Terry Fox research teams.
Deadline for application summaries: April 23, 2012
Deadline for full application: June 4, 2012
For more info: www.tfri.ca/programs/foundation_2012_rfa.asp
U.S. Department of Defense Bone Marrow Failure Research Program
The objective of the BMFRP is to fund scientifically meritorious research focused on BMF syndromes and their long-term sequelae. Investigator-initiated research is encouraged in the areas of congenital or acquired BMF. Studies focused on BMF syndromes and their progression to other malignancies such as leukemia, are acceptable. However, research primarily focused on myeloproliferative neoplasms, leukemia, or other malignancies is discouraged. Translational projects including bone marrow transplantation studies are encouraged to address issues that are unique to BMF syndromes. Stem cell biology studies should be clearly related to BMF syndromes.
Award mechanisms are:
• Idea Award
• Postdoctoral Award
Deadline for Pre-Applications: Apr 18, 2012
For more info: http://cdmrp.army.mil/funding/bmfrp.shtml
U.S Department of Defense Multiple Sclerosis Research Program
The MSRP challenges the scientific community to design innovative research relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (MS).
Idea Awards support conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries in understanding the causes and progression of MS and/or improvements in patient care and/or quality of life.
Preliminary data that are relevant to MS and the proposed research project should be included Clinical trials are not allowed.
Deadline for pre-applications: April 24, 2012
For more info: http://cdmrp.army.mil/funding/msrp.shtml
U.S. Department of Defense Neurofibromatosis Research Program
Award mechanisms include:
• Clinical Trial Award
• Exploration - Hypothesis Development Award
• Investigator-Initiated Research Award
• New Investigator Award
Deadline for pre-applications: May 10, 2012
For more info: http://cdmrp.army.mil/funding/nfrp.shtml
U.S Department of Defense Peer Reviewed Medical Research Program
Congressionally Directed Topic Areas: The FY12 PRMRP will solicit research applications for the following 22 topics areas: Arthritis, Composite Tissue Transplantation, Dystonia, Drug Abuse, Epilepsy, Food Allergies, Fragile X Syndrome, Hereditary Angioedema, Inflammatory Bowel Disease, Interstitial Cystitis, Listeria Vaccine for Infectious Diseases, Lupus, Malaria, Nanomedicine for Drug Delivery Science, Neuroblastoma, Osteoporosis and Related Bone Disease, Paget's Disease, Polycystic Kidney Disease, Post-Traumatic Osteoarthritis, Scleroderma, Tinnitus, and Tuberculosis.
Military Relevance: Relevance to the health care needs of the military service members, veterans, and beneficiaries is a key feature of each FY12 PRMRP award mechanism.
Award mechanisms:
- Clinical Trial Awards
- Discovery Awards
- Investigator-Initiated Research Awards
- Technology/Therapeutic Development Awards
Deadlines for pre-applications: varies by program
For more info: http://cdmrp.army.mil/funding/prmrp.shtml
U.S. Department of Defense Prostate Cancer Research Program
Award mechanisms include:
EMPHASIS ON IMPACT: (5)
• Biomarker Development Award
• Clinical Exploration Award
• Health Disparity Research Award (Modified!)
• Laboratory - Clinical Transition Award
• Transformative Impact Award
EMPHASIS ON INNOVATION (3)
• Exploration - Hypothesis Development Award
• Idea Development Award
• Synergistic Idea Development Award
Deadlines: varies according to award mechanism
For more info: http://cdmrp.army.mil/funding/pcrp.shtml
U.S. Department of Defense Tuberous Sclerosis Complex Research Program
Award mechanisms include:
• Clinical Trial Award
• Exploration - Hypothesis Development Award
• Idea Development Award
Deadline for pre-applications: May 10, 2012
For more info: http://cdmrp.army.mil/funding/tscrp.shtml
March 15, 2012
American Shoulder And Elbow Surgeons 2013 Research Grant
The objective of the ASES Research Grant is to encourage new investigators by providing seed and start-up funding for promising shoulder and elbow research projects.
Amount: up to $20,000
Deadline: Sept 6, 2012.
For more info: http://www.ases-assn.org/?p=physic-grants
Anesthesia Patient Safety Foundation 2012 Grant Program
The APSF Grant Program supports research directed towards enhancing anesthesia patient safety. Its major objective is to stimulate and fund studies that will clearly improve patient safety and lead to prevention of mortality and morbidity resulting from anesthesia mishaps. For the 2012-2013 funding cycle, APSF is placing a specific emphasis on Patient Safety Education and Medication and Device Safety.
Amount: $150,000
Deadline: May 06, 2012
For more info: http://www.apsf.org/grants_guidelines.php
Center for High-Throughput Minimally-Invasive Radiation Biodosimetry
We are seeking applications for pilot project funding relating to high-throughput minimally-invasive radiation biodosimetry.
The projects will be part of a joint NIH-funded program involving Columbia University, Georgetown University, Lovelace Respiratory Research Institute, Translational Genomics Research Institute, New York University, and University of Bern. Details of the program can be found at www.cmcr.columbia.edu.
We currently support biodosimetry projects using cytogenetic, gene expression, and metabolomic endpoints, and we are looking for biodosimetry-oriented pilot projects which will either complement these areas, or open up new research avenues. The projects can be biologically- or physically-based, but must ultimately be directed towards practical high-throughput radiation biodosimetry or dosimetry, after external photon or neutron exposure, or internal radiation exposure. Innovative proposals for testing new concepts are encouraged.
Amount: maximum of $100,000
Deadline: Mar 30, 2012
For more info: http://www.cmcr.columbia.edu/
Autism Speaks invites both Full- and Pilot-Level Treatment research grant applications to conduct innovative clinical studies of novel interventions for individuals with Autism Spectrum Disorders (ASD) throughout the lifespan. These may include medical, complementary and alternative forms of health care; pharmacological, and/or behavioral/psychosocial interventions; and evaluation of the efficacy, safety or therapeutic benefits of interventions.
Amount: Full-level research grants are awarded at a maximum of $150,000 per year, for between 1 and 3 years. Pilot-level research grants are awarded at a maximum of $60,000 per year, for between 1 and 2 years.
Deadline for Letter of Intent: May 02, 2012
For more info: http://www.autismspeaks.org/science/research/grants/open_grants_how_to_apply.php
Grand Challenges Explorations / Gates Foundation
Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions, is now accepting grant proposals for its latest application round. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies.
Proposals are being accepted online on the following topics:
• New Approaches for the Interrogation of Anti-malarial Compounds
• Aid is Working. Tell the World
• Design New Approaches to Optimize Immunization Systems
• Explore New Solutions in Global Health Priority Areas
• Protect Crop Plants from Biotic Stresses From Field to Market
Deadline: May 15, 2012
Amount: Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million.
Full descriptions of the new topics and application instructions are available at: www.grandchallenges.org/explorations
Huntington Society of Canada - New Pathways for HD Research
The Huntington Society of Canada (HSC) is interested in fostering innovative lines of enquiry that will eventually lead to the next generation of targets for the treatment of Huntington disease (HD). The Society is now calling internationally for research proposals that specifically address any of the objectives listed below:
a. Explore early mechanisms of disease in Huntington disease through unbiased analysis of genetically defined tissues or cells with a goal of uncovering or sharing the discovery of new pathways or processes affected in HD;
b. Elucidate the normal biological functions of the huntingtin protein, with experiments involving either endogenous normal huntingtin or huntingtin protein in a full-length context;
c. Further the understanding of the impact on HD of increasing numbers of alleles or repeats and the CAG DNA expansion process;
d. Further the analysis of modifier genes to determine the impact on various aspects of HD.
Amount: up to CAD$150,000
Deadline: Apr 19, 2012
For more info: http://www.huntingtonsociety.ca/english/content/?page=103
Funded by the Office of the Vice-President (Research & International Relations), Western's International Research Awards are offered to support the cost of *international research projects of modest scope. This program provides seed money for one-time requests and projects of short duration, which involve a significant international component.
Amount: maximum of $7,000
Deadline: May 15, 2012
For more info: http://www.uwo.ca/research/funding/internal/international_research_awards.html
Johns Hopkins Global Center for Childhood Obesity
The Johns Hopkins Global Center for Childhood Obesity (JHGCCO) is seeking applications to jumpstart systems-oriented childhood obesity research in a rapidly changing physical or policy environment by supporting opportune pilot and feasibility projects with timelines that would not allow funding through the regular NIH review cycles.
We invite applications from investigators in the United States and globally for innovative pilot and feasibility projects using systems science concepts and framework to examine time sensitive environmental mechanisms or policy changes related to the childhood obesity epidemic. Projects should have the potential to inform the development or confirmation of community- or population-based interventions.
Amount: $20,000-$30,000
Deadline: March 30, 2012
For more info: http://www.jhgcco.org/announcement_20120215.html
The Jerome Lejeune Foundation funds research into treatments for intellectual disabilities of genetic origin, especially, but not limited to, Down syndrome. The Foundation's specific research interest is to discover a means to prevent and/or treat genetic intellectual disabilities in order to improve the memory, speech, and cognition of patients.
The Jerome Lejeune Foundation will consider all proposals which have as their goal advancing scientific knowledge which leads to the discovery of treatments to improve the intellectual capacities of those affected by genetic illness. The Foundation provides no funding for research into autism. Therapeutically oriented projects will be given priority and may receive consideration for larger grants. Funding for research congresses and teaching programs may also be considered.
Amount: Maximum grant is $25,000 for one year or $50,000 for two years
Deadline: Mar 25, 2012
For more info: http://www.fondationlejeune.org/index.php?option=com_content&task=view&id=128&Itemid=261
Ontario Genomics Institute - SPARK
With the SPARK program, the Ontario Genomics Institute (OGI) seeks to provide catalytic funding for high-impact, high-risk and/or early-stage technology development in the Genomic Sciences. The SPARK grants are intended for innovative projects which have previously not been funded and/or where funding would be difficult to obtain due to the early-stage nature of the proposed research. Outcomes of such projects should enable follow-on investment or funding for further research or development that will ultimately lead to a commercial product.
The overall goal of the SPARK program is to catalyze new research directions and increase the competitiveness of Ontario research and its life science sector. The ideal proposal will focus on developing technologies that create new capabilities or scientific resources that will be transformative for the field of Genomics/*omics sciences. Projects should address major hurdles or opportunities for Genomic Sciences and in the long term create innovative technologies that are easy to commercialize.
Amount: up to $50,000
Deadline: May 21, 2012
For more info: http://www.ontariogenomics.ca/research/spark-program-technology-development-2012/
U.S. Department of Defense ALS Research Program
The goal of ALSRP is to promote the introduction of improved therapies for ALS by encouraging ALS investigators to undertake preclinical studies of novel and existing agents. Mechanisms for funding:
• Therapeutic Development Award
• Therapeutic Development Award
Deadline for pre-applications: April 9, 2012
For more info: http://cdmrp.army.mil/funding/alsrp.shtml
U.S Department of Defense Gulf War Illness Research Program
The GWIRP focuses its funding on innovative projects that have the potential to make a significant impact on Gulf War Illness, improving the health and lives of affected service members and their families. Mechanisms include:
• Investigator-Initiated Research Award
• Innovative Treatment Evaluation Award
• Clinical Trial Award
Deadline for pre-applications: April 9, 2012
For more info: http://cdmrp.army.mil/funding/gwirp.shtml
U.S. Department of Defense Peer Reviewed Medical Research Program
The vision of the PRMRP is to improve the health and well-being of all military service members, veterans, and beneficiaries. The PRMRP challenges the scientific and clinical communities to address one of the FY12 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; or clinical trials that address an immediate clinical need.
The FY12 PRMRP will solicit research applications for the following 22 topics areas: Arthritis, Composite Tissue Transplantation, Dystonia, Drug Abuse, Epilepsy, Food Allergies, Fragile X Syndrome, Hereditary Angioedema, Inflammatory Bowel Disease, Interstitial Cystitis, Listeria Vaccine for Infectious Disease, Lupus, Malaria, Nanomedicine for Drug Delivery Science, Neuroblastoma, Osteoporosis and Related Bone Disease, Paget's Disease, Polycystic Kidney Disease, Post-Traumatic Osteoarthritis, Scleroderma, Tinnitus, and Tuberculosis.
Deadline for Pre-application: April 10, 2012
For more info: http://cdmrp.army.mil/pubs/press/2012/12prmrppreann.shtml
February 29, 2012
Alliance for Cancer Gene Therapy - 2012 Investigator’s Award in Clinical Translation of Gene Therapy for Pancreatic Cancer Research Grant
Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of gene therapy approaches to the treatment of cancer. To this end, ACGT offers awards in Clinical Translation of Gene Therapy for Cancer, to qualified scientists at the assistant professor level and above. This award is specifically for those conducting Gene Therapy Research for Pancreatic Cancer.
Amount: maximum of $500,000 over 2-3 years
Deadline for abstract: Mar 7, 2012
For more info: www.acgtfoundation.org
Anesthesia Patient Safety Foundation Grant Program
The Anesthesia Patient Safety Foundation (APSF) Grant Program supports research directed towards enhancing anesthesia patient safety. Its major objective is to stimulate and fund studies that will clearly improve patient safety and lead to prevention of mortality and morbidity resulting from anesthesia mishaps.
Amount: maximum of $150,000
Deadline: May 6, 2012
For more info: http://www.apsf.org/grants_guidelines.php
Michael J. Fox Foundation for Parkinson’s Research Alpha-Synuclein Biology 2012
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is launching this funding initiative to promote a better understanding of the biology of gene/protein alpha-synuclein, which will help to inform and guide therapeutic development. Applicants may submit a proposal focused on a relevant area of alpha-synuclein for consideration of a two-year, USD $200,000 award.
Deadline for Pre-Proposals: March 29, 2012
For more info: http://www.michaeljfox.org/research_openFundingPrograms_program.cfm?ID=56
Canada Council for the Arts - Killam Research Fellowships
These awards, which are administered by the Canada Council, provide support to scholars of exceptional ability who are engaged in research projects of broad significance and widespread interest. The awards honour the memory and exceptional achievements of Mrs. Dorothy J. Killam’s husband, Izaak Walton Killam.
The fellowships are awarded annually, on a competitive basis, to support scholars doing research in any of the following fields:
• humanities
• social sciences
• natural sciences
• health sciences
• engineering
• studies linking any of the disciplines within these fields.
The fellowships provide two years of release time from teaching and administrative duties to individual scholars who wish to pursue independent research. The fellowships are awarded to individuals, but the funds are paid to and administered by universities or research institutes.
Deadline: May 15, 2012
For more info: http://killam.canadacouncil.ca/
Grand Challenge 2012 - Saving Lives at Birth: A Grand Challenge for Development (Round II)
United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and UK’s UK Department of International Development (DFID) have joined together to launch the second wave of Saving Lives at Birth: A Grand Challenge for Development.
Together, we call for groundbreaking prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the time of childbirth. The estimated 2.6 million stillbirths, 3.1 million neonatal deaths and 360,000 maternal deaths that occur globally each year signal a major gap for intervention specifically around childbirth and the early postnatal period – a time when mothers and babies are most vulnerable and global progress in reducing mortality has been particularly poor. This gap in interventions is particularly acute in poor, underserved communities that are the most difficult to reach and among women who are disadvantaged.
Innovative ideas that can leapfrog conventional approaches are critical in this area. If we are to accelerate substantial and sustainable progress in reducing maternal and newborn deaths and stillbirths at the community level, we need innovative prevention and treatment approaches across three main domains:
(1) Science & technology;
(2) Service delivery; and
(3) Demand-side innovation that empowers pregnant women and their families to practice healthy behaviors and be aware of and access health care during pregnancy, childbirth and the early postnatal period, especially the first two days after birth.
We are particularly interested in investing in approaches that incorporate the latest scientific, technological, behavior change, and information and communication advances into radical solutions.
Deadline: April 2, 2012
For more info: http://savinglivesatbirth.net/sites/default/files/gcd_slb-_rd2_final_rfa.pdf
International Rett Syndrome Foundation
IRSF announces the availability of Regular Research Grants for international biomedical research to promote the understanding of MeCP2 in the pathogenesis of the neurobehavioral phenotype of Rett syndrome (RTT). These grants are designed to assist investigators establish hypotheses relevant to RTT research and obtain future funding from other agencies. IRSF seeks to gain a better understanding of the underlying pathology of the disorder leading to an amelioration of the symptoms and a cure for RTT. IRSF seeks to encourage research that encompasses innovative therapeutic approaches and state of the art diagnostic techniques.
IRSF encourages applications within the following emphasis areas:
1. Understanding the role of MeCP2 during normal brain development
2. Characterizing the role of MeCP2, including MeCP2 target genes, in normal structure and function of the developing and adult nervous system
3. Determination of the relationship between patterns of expression of MeCP2 and related proteins in the nervous system and the neurologic and behavioral phenotypes of patients with RTT and/or related animal models
4. The investigation of neuronal abnormalities that result from MeCP2 dysfunction
5. Understanding mechanisms and systems leading to aberrant behavior in RTT
6. The development of assistive technologies to improve the quality of life of individuals affected by RTT
7. Support for other advances in therapy such as physical therapy, communication and education
Amount: maximum of $100,000 over two years
Deadline for letter of intent: Aug 01, 2012
For more info: http://www.rettsyndrome.org/index.php?option=com_content&task=view&id=560&Itemid=944
Kidney Foundation of Canada - 2012 Competition Focusing on Alport Syndrome
The Kidney Foundation of Canada had announced the first call of a new annual Research Grant competition focusing on Alport Syndrome.
The KFOC will fund one excellent application that is determined to be relevant to the following research areas:
- Understanding the cause, pathophysiology or treatment of Alport Syndrome.
Amount: $100,000
Deadline: Apr 15, 2012
For more info: http://www.kidney.ca/page.aspx?pid=2256
Lesbian Health Fund Grants Program
The mission of the Lesbian Health Fund is to improve the health of lesbians and other sexual minority women and their families through research.
Amount: range from $500 to $10,000
Deadlines: May 15, 2012; Oct 15, 2012
For more info: http://www.glma.org/index.cfm?fuseaction=Page.viewPage&pageId=922&parentID=594&nodeID=1
Multiple Myeloma Research Foundation - Senior Research Awards
The Multiple Myeloma Research Foundation (MMRF) seeks proposals for the 2012 Senior Research Award Program, an initiative supporting researchers who have more than five years experience in blood cancer research. The goal of this initiative is to accelerate the development of therapeutic approaches for myeloma and may include proposals in basic science or translational research. The Award Committee will consider most favorably translational research proposals that will identify or contribute to novel therapeutic approaches for myeloma in an accelerated timeframe.
Amount: up to $100,000/year for two years
Deadline: Mar 27, 2012
For more info: http://www.themmrf.org/research-programs/for-academic-researchers/grant-opportunities.html
National Multiple Sclerosis Society Pilot Research Grants
The National Multiple Sclerosis Society provides funds for limited short-term support of research in areas where preliminary data are scant or nonexistent. This program is designed to support unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. Projects that are simply extensions of on-going research or that already have ample supporting data will not be considered.
Amount: maximum of $40,000/one year
Deadlines: April 3, 2012; July 3, 2012; October 2, 2012
For more info: http://www.nationalmssociety.org/for-professionals/researchers/get-funding/pilot-research-grants/index.aspx
Partnership for Clean Competition RFP for the Detection of Human Growth Hormone Use
The Partnership for Clean Competition welcomes proposals that would improve the detection methods for misuse of hGH.
Deadlines for pre-applications: March 1, July 1 and November 1
For more info: http://www.cleancompetition.org/rfps.aspx
Partnership for Clean Competition RFP for the Detection of Performance Enhancing Drugs Using Low Volume and Alternative Specimens
The PCC is requesting proposals for new and innovative approaches for collecting smaller volumes, whether blood, urine, saliva, or other specimens, and for methods necessary to detect known performance enhancing drugs in these samples.
Deadlines for pre-applications: March 1, July 1 and November 1
For more info: http://www.cleancompetition.org/rfps.aspx
U.S. Department of Defense Breast Cancer Research Program
The Congressionally Directed Medical Research Programs has released the following Breast Cancer Research Program (BCRP) funding mechanisms for Fiscal Year 2012:
• Postdoctoral Fellowship Award
• Idea Award
• Impact Award
• Era of Hope Scholar Award
• Innovator Award
• Clinical Translational Research Award
• Transformative Vision Award
Deadline: Due dates range from April 26, 2012 to May 3, 2012 depending on the award mechanism.
For more info: http://cdmrp.army.mil/funding/bcrp.shtml
U.S. Department of Defense Ovarian Cancer Research Program
The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $16 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support innovative, high-impact ovarian cancer research. The OCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP). Opportunities include:
• Ovarian Cancer Academy Award
• Pilot Award
• Teal Innovator Award
• Synergistic Translational Leverage Award
Deadline: Due dates vary depending on the award mechanism
For more info: http://cdmrp.army.mil/funding/ocrp.shtml
February 15, 2012
Autism Speaks Request for Applications: Treatment Research Grants: Full- and Pilot-Level
Autism Speaks invites both Full- and Pilot-Level Treatment research grant applications to conduct innovative clinical studies of novel interventions for individuals with Autism Spectrum Disorders (ASD) throughout the lifespan. These may include medical approaches including complementary and alternative forms of health care and pharmacological treatments, as well as behavioral and/or psychosocial interventions, and evaluation of the efficacy, safety or therapeutic benefits of all types of interventions. Also appropriate are animal model studies that test the effects of novel compounds for reducing autism symptoms.
Amount: Full-level research grant - $150,000/year maximum for 1-3 years
Pilot-level research grant - $60,000/year maximum for 1-2 years
Deadline for Letter of Intent: February 23, 2012
Operating Grants provide funds to hepatobiliary research investigators to pursue major research projects.
Amount: up to $60,000/year for maximum of two years
Deadline: Apr 02, 2012
For more info: http://www.liver.ca/liver-education-liver-research/research/grant-programs/submission-guidelines.aspx
Epilepsy Foundation Targeted Research Initiative for Health Outcomes
The Targeted Research Initiative for Health Outcomes targets an important need for research to understand how different components of health care systems affect outcomes in people with epilepsy. The purpose of this initiative is to support research that generates initial data leading to more extensive projects that will generate knowledge that will ultimately improve the healthcare of persons with epilepsy. The broad focus of the proposal includes methodological aspects of health and outcome measurement, health care needs assessment, nature and determinants of disparities in healthcare, access to care, quality of life, comparative effectiveness research, insurance and healthcare system issues, and methods of health care delivery.
Amount: up to $50,000 maximum for one year
Deadline: March 21, 2012
For more info: http://www.epilepsyfoundation.org/research/grant-and-fellowship-opportunities.cfm
Epilepsy Foundation Targeted Research Initiative for Women with Epilepsy
The Targeted Research Initiative for Women with Epilepsy grant program was developed to support research that generates initial data leading to more extensive projects that will have direct relevance to care of women with epilepsy. Research should focus on investigation of one of the many areas that preferentially affect women with epilepsy during the reproductive life cycle. The research may target any point along the reproductive spectrum, including puberty through menopause. Examples of topics of interest include, but are not limited to, the following areas: neuroendocrine disorders, hormone influence on seizure susceptibility, infertility, polycystic ovarian syndrome, contraceptive strategies, complications during pregnancy, and pregnancy outcomes.
Amount: up to $50,000 maximum for one year
Deadline: March 21, 2012
For more info: http://www.epilepsyfoundation.org/research/grant-and-fellowship-opportunities.cfm
Bill & Melinda Gates Foundation - Request for LOIs: Development of a Rapid Immunity Assessment Tool
The Bill & Melinda Gates Foundation is focused on ensuring that all children have equal access to the immunizations they need to protect them against vaccine-preventable diseases. The Gates Foundation endorses and strives for the goals outlined by the Global Immunization Vision and Strategy (GIVS), of at least 90% vaccination coverage in every country, and at least 80% coverage in every district.
Regular measurement of vaccination coverage across the developing world is important to assess progress against coverage goals, and to identify areas of weakness in delivery systems so that corrective action can be taken. Current tools and processes to measure vaccination coverage have significant limitations, which can lead to reliance on imprecise estimates of coverage.
This Request for Letters of Inquiry (RFLOI) will solicit proposals from organizations to develop a prototype and detailed commercialization plan for an immunity assessment tool that can more accurately measure vaccination coverage in the developing world.
Deadline: Mar 27, 2012
For more info: http://www.gatesfoundation.org/vaccines/Pages/rfp-immunity-assessment-tool.aspx
Genome Canada-CIHR Personalized Medicine
Genome Canada is seeking proposals for large-scale research projects which focus on the application of genomics in the area of Genomics and Personalized Health. The competition will be a partnership with the Canadian Institutes of Health Research (CIHR) to build on the complementary mandates of Genome Canada and CIHR and provide an opportunity to maximize the effectiveness of the research communities, infrastructure and resources supported by both organizations.
In this competition, Genome Canada intends to fund applied research with a clear path leading to patient and socioeconomic benefit. In particular, projects must make sense from a health economic perspective and ideally some preliminary data supporting such claims should be included in the application.
Deadline: Feb 27, 2012
For more info: http://www.ontariogenomics.ca/research/lsarp-2012
Grand Challenges Canada - Canada’s Rising Stars in Global Health
Grand Challenges Canada is pleased to announce Canada’s Rising Stars in Global Health Request for Proposals, Round Three. This unique program is a call to action to Canada’s early-career innovators to make their contribution to global health. Grand Challenges Canada’s goal is to tap into the creativity, knowledge and skills of Canada’s scientists, entrepreneurs and social innovators to solve some of the most persistent health challenges in the developing world through Integrated Innovation.
Round Three provides $100,000 in seed grants for up to 20 successful proposals. If the ideas are robust, effective, and proven, the innovators will be eligible to apply for additional scale–up funds of up to $1 million for each proposal.
Deadline: Mar 23, 2012
For more info: http://www.grandchallenges.ca/grand-challenges/gc1-stars/canadasrisingstars/
Applications are now being accepted for five new RFAs for LFA's 2012 National Research Program:
• Advancement of Research on Stem Cells in Lupus
• Neuropsychiatric Lupus
• Pediatric Lupus: Quality of Life
• Pediatric Lupus Nephritis
• Cutaneous Lupus
Deadline for Letter of Intent: Feb 16, 2012
For more info: http://www.lupus.org/webmodules/webarticlesnet/templates/new_researchlfa.aspx?articleid=155&zoneid=31
The National MPS Society is seeking to fund research projects that would be likely to generate strong preliminary data for major funding in the following areas (special consideration will be given to new investigators):
1. The support of basic or clinical research for MPS II - One (1) $90,000 two year grant: $45,000 awarded in 2012 and in $45,000 in 2013
2. The support of basic or clinical research for MPS IV - One (1) $80,000 grant: $40,000 awarded in 2012 and $40,000 in 2013
The Society is also offering an MPS III Grand Challenge Grant, to support an MPS III clinical trial, or to study either a therapy or a biomarker that has passed the proof of concept stage but requires further pre-clinical or clinical testing. Biomarkers must be potentially useful in monitoring the therapeutic response in the central nervous system in clinical trials. Proposals for therapies or biomarkers for other MPS and related diseases will be considered, provided they are applicable to MPS III.
Deadline: Mar 15, 2012
For more info: http://www.mpssociety.org/posts/news/call-for-letters-of-intent/
Partnership for Clean Competition
The Partnership for Clean Competition will support high-quality, high-impact, novel research that has a high likelihood of success and of resulting in methods or products that will advance the anti-doping field and ensure integrity in sport. PCC research priorities are as follows:
1. Improving existing analytical methods to detect particular drugs, e.g., GH, IGF-1 EPO, hCG, discrimination of exogenous and endogenous steroids, screening methods for common steroids, and stimulants
2. Developing analytical methods to detect performance enhancing drugs not currently detectable, e.g., selective Androgen Receptor Modulators, identifying designer steroids, autologous blood transfusions, and other forms of enhanced oxygen transport and use
3. Discovering cost effective approaches for testing widely abused substances
4. Longitudinal studies to document urinary excretion patterns, metabolism and dose-concentration
5. Critical Reviews of the literature from which to develop Position Papers to support interpretation of laboratory data
6. Alternative specimens, (e.g., hair, sweat, saliva, interstitial fluid) for testing
7. Better understanding of how banned substances are used and the implications for the long-term health consequences of athletes
Deadlines for Stage 1 applications: Mar 1, 2012; Jul 1, 2012; Nov 1, 2012
For more info: http://www.cleancompetition.org/grant-pre-application.aspx
Preeclampsia Foundation - Vision Grant Award Program
Vision Grants are intended to provide initial funding for innovative ideas focused on the pathophysiology, diagnosis or treatment of preeclampsia, HELLP syndrome and other hypertensive disorders of pregnancy that might otherwise not be pursued due to lack of funding. All novel, well-considered research topics are encouraged.
While preliminary data is not required, careful development of hypothesis based on existing information is expected. Although these awards are ideal for young investigators, they are not limited to young investigators. They should, however, be directed towards novel rather than well established lines of research, and/or have the near-term potential for clinical application.
Special consideration will be given to ideas that address the Preeclampsia Foundation's most immediate mission: To stop preventable death and disability of mothers and babies by eliminating delays in diagnosis or implementation of known practices, developing new practices, and helping women and families through the impact of preeclampsia. Consideration will also be given to health services research focused upon the improvement of health care delivery such that improved outcomes are attained. The foundation is not, however, limited by this focus - they are interested in all innovative, well-considered ideas in the field of preeclampsia.
Amount: $25,000
Deadline: May 18, 2012
For more info: http://www.preeclampsia.org/research/research-funding
January 31, 2012
American Academy of Implant Dentistry Research Foundation Research Grants Program
The American Academy of Implant Dentistry Research Foundation (AAIDRF) Research Grants Program is intended to provide limited support for meritorious dental implant research projects which include, but are not limited to, the following purposes:
• To conduct research which determines the feasibility of a larger research project. This may be described as the conduct of pilot studies of venture research.
• To develop and test new techniques and procedures.
• To carry out a small clinical or animal research project.
• To analyze existing data.
Investigators from any scientific discipline and at any stage of their career may apply for a grant. These awards are appropriate for new investigators and those changing areas of research or resuming research careers.
Amount: up to $25,000 over two years
Deadline: Aug 01, 2012
For more info: http://www.aaid-implant.org/research_foundation/index.html
CNIB Baker Applied Research Fund
The CNIB Baker Applied Research Fund supports research that is focused on the social, educational, cultural and rehabilitative needs of Canadians living with vision loss, and the application of assistive devices to meet these needs. This program is intended both to advance the career development of new investigators, and to encourage senior researchers to develop programs of applied research. Proposals are invited from both.
Deadline: Jan 15, 2013
For more info: http://www.cnib.ca/en/research/funding/eabaker-applied/
Earl Russell Trainee Grants in Pain Research
Mini-grants are available annually to provide seed funding for pain research projects initiated by trainees registered at Western.
Amount: up to $10,000
Deadlines: April 01, 2012; Oct 01, 2012
For more info: contact Dr Dwight Moulin, Earl Russell Chair Pain Research, at dwight.moulin@lhsc.on.ca
Floyd Award for Bladder Cancer Research
The purpose of this grant is to encourage research that will increase the understanding of bladder cancer risk, biology, prevention and treatment while encouraging young investigators to pursue a career in bladder cancer research.
At the time the application is submitted, applicant must be a resident, graduate student, clinical research fellow, post-doctoral fellow, or junior faculty at an academic facility, teaching hospital or research institution at the time of application. Faculty members are eligible if within the first 5 years of faculty appointment.
Amount: $25,000/one year
Deadline: March 29, 2012
For more info: http://www.bcan.org/medical/research-award/
Human Frontier Science Program - Young Investigators' Grants and Program Grants
The HFSP supports innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries. In the past decade biological research has become increasingly quantitative rather than descriptive. The participation of scientists from disciplines outside the traditional life sciences such as biophysics, chemistry, computational biology, computer science, engineering, mathematics, nanoscience and physics has contributed to this change and will continue to do so. Such collaborations have opened up new approaches for understanding the complex structures and regulatory networks that characterize living organisms, their evolution and interactions.
There are two types of grant: Young Investigators' Grants are for teams of scientists who are all within 5 years of establishing an independent laboratory and within 10 years of obtaining their Ph.D.s. Program Grants are for independent scientists at all stages of their careers, although the participation of younger scientists is especially encouraged.
Research grants are available for projects concerned with basic approaches to understanding the complex mechanisms of living organisms. Topics covered range from molecular and cellular approaches to biological functions to systems neuroscience including cognitive functions. The HFSP funds novel collaborations that bring biologists together with scientists from other disciplines to focus on problems at the frontiers of the life sciences.
Deadline for pre-registration: Mar 21, 2012
Deadline for letters of intent: Mar 28, 2012
For more info: http://www.hfsp.org/how/appl_forms_RG.php
Huntington Society of Canada - 2012 Navigator Research Program
The goal of the NAVIGATOR Research Program is to provide funding for scientific research of direct and immediate relevance to Huntington Disease in Canada; to provide a platform for the future recruitment of outstanding investigators to HD research; to facilitate research collaboration nationally and internationally, and research which is relevant to other neurodegenerative disorders.
Amount: up to $75,000 per year for one or two years
Deadline: April 19, 2012
For more info: http://www.huntingtonsociety.ca/english/content/?page=78
The IOCDF is committed to finding and promoting effective treatment for everyone with Obsessive-Compulsive Disorder (OCD). Research is vital to understanding more about OCD and related disorders and as a way of improving treatment. Promoting research into the causes and treatment of OCD and related disorders is a top priority of the IOCDF. The IOCDF awards grants to investigators whose research focuses on the nature, causes and treatment of OCD and related disorders. The IOCDF is hoping that many junior investigators will apply this year as grant from the foundation will help build their research programs and keep them interested in studying the field of OCD and related disorders. Senior investigators may also ask for grant funding for projects that would provide pilot data for future larger scale federal grant applications.
Amount: $25,000 - $50,000
Deadline: Feb 29, 2012
For more info: http://www.ocfoundation.org/Research.aspx
Lupus Research Institute - International Distinguished Innovator Awards
The Lupus Research Institute (LRI) invites applications for a new global funding program that will run in parallel with our established Novel Research Grant program. LRI Distinguished Innovator Awards will provide outstanding scientists with substantial support for up to four years to conduct novel research into the fundamental causes of lupus and so provide new directions towards a cure or prevention.
The LRI welcomes novel, hypothesis- or discovery-driven proposals in human and/or animal model based lupus research. The research proposal must aim to uncover the fundamental causes of lupus and present a compelling vision of how the discovery would lay the groundwork for a potential cure or prevention, as opposed to suppressive treatments for lupus. Continuations of long-term projects will not be considered.
Amount: up to $250,000 per year, for a term of up to four years
Deadline for Letter of Intent: Feb 29, 2012
For more info: http://www.lupusresearchinstitute.org/research/2012-lri-distinguished-innovator-awards
March of Dimes - Research Program
The March of Dimes invites qualified scientists to submit applications for research grants directed at the prevention of birth defects. Research subjects appropriate for support by the March of Dimes include basic biological processes governing development, genetics, clinical studies, studies of reproductive health, environmental toxicology, and social and behavioral studies.
Deadline for Letter of Intent: April 30, 2012
For more info: http://researchgrants.modimes.org/MODGrants/LOI/LOI_Submit.asp
Multiple Myeloma Research Foundation - Senior Research Awards
The Multiple Myeloma Research Foundation (MMRF) offers Senior Research Awards to investigators with an interest in myeloma who have been working in blood cancer research for a minimum of five years. The goal of this initiative is to accelerate the development of therapeutic approaches for myeloma.
Amount: up to $100,000/year for two years
Deadline: Mar 27, 2012
For more info: http://www.themmrf.org/research-programs/for-academic-researchers/grant-opportunities.html
National Rosacea Society
Because the etiology of rosacea is unknown, high priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition. Studies may also be funded in such areas as epidemiology, predisposition, quality of life and associations with environmental and lifestyle factors. Product development studies (e.g., drug or device testing), which are more appropriately funded by commercial sources, will not be considered.
Amount: $10,000 - $25,000
Deadline: May 01, 2012
For more info: http://www.rosacea.org/grants/index.php
Physicians' Services Incorporated Foundation
The Foundation’s granting interests are in two areas: education of practising physicians and health research with an emphasis on research relevant to patient care.
Programs include:
• Health Research Grants
• Healthcare Research by Community Physicians
• Educational Fellowships for Practicing Physicians
• Resident Research Grants
Note: Per PSI guidelines, applications to PSI Foundation from London researchers must be submitted through Western. PSI applications cannot be submitted through Lawson.
Deadlines: Mar 01, 2012: June 7, 2012; Sept 13, 2012
For more info: http://www.psifoundation.org/
Prader-Willi Syndrome Association
The Prader-Willi Syndrome Association USA is pleased to offer grant assistance for scientific researchers with an interest in improving the lives of those with Prader-Willi syndrome (PWS). PWSA (USA) is especially interested in supporting research projects that have the potential for immediate and high impact to the PWS community. However, PWSA also seeks to balance its research funding between "basic" and "applied" research in order to seek new insights that could benefit its membership right away as well as to elucidate the causes of Prader-Willi syndrome to spur more potent and complete therapies in the future.
Amount: $75,000/year for a maximum length of two years
Deadline: Mar 06, 2012
For more info: http://www.pwsausa.org/research/letter_of_intent.htm
Prevent Blindness America - Investigator Award Research Grant
The 2011 Prevent Blindness America Investigator Award provides funding for research investigating public health related to eye health and safety. Applications will be accepted in the following priority areas in adult vision, children's vision, or eye injury:
- Burden/economic aspects of eye disease/vision loss on society
- Best practices to integrate vision screening/follow up care to system care access
- Vision program effectiveness/evaluation
Amount: from $10,000 to $30,000
Deadline: Mar 30, 2012
For more info: http://www.preventblindness.org/investigator-awards
Public Health Agency of Canada - Canadian Diabetes Strategy
The Public Health Agency of Canada (PHAC) is pleased to invite eligible organizations to submit a proposal for funding under the Community-Based Programming Component of the Canadian Diabetes Strategy for 2012 to 2014. The CDS targets information to Canadians who are at higher risk for diabetes (e.g., family history, overweight/obese, pre-diabetic, certain ethnic groups), and/or living with diabetes to aid in the prevention of diabetes-related complications.
Priority Areas for funding are:
• Screening and early detection; and
• Self-management
Within these Priority Areas, there may also be a secondary focus on:
• Kidney disease;
• Diabetic retinopathy;
• Diabetic foot ulcers;
• Cardiovascular disease; or
• Mental illness/mental health
Deadline: March 16, 2012
For more info: http://www.phac-aspc.gc.ca/cd-mc/diabetes-diabete/diabetes_funding-financement_diabetes-eng.php
Research grants are available to clinicians or established scientists working on epilepsy or related subjects.
Amount: $25,000
Deadline: Jan 15, 2013
For more info: http://www.savoy-foundation.ca/eng/mission/defaut.htm
The purpose of the Scoliosis Research Society (SRS) is to foster the optimal care of all patients with spinal deformities. This grant is designed specifically for new investigators who have a preliminary concept they would like to develop into a research project.
Amount: $10,000
Deadlines: Apr 01, 2012; Oct 01, 2012
For more info: http://www.srs.org/research/
Solving Kids' Cancer - Therapeutic Development Initiative (TDI) - Funding for Development of New Therapies for Pediatric Cancers
The TDI supports clinical testing of promising therapies that may significantly and fundamentally improve treatment for children with pediatric cancer. While SKC values pre-clinical research, only clinical studies are supported via the TDI program. Final pre-clinical work that is requisite to the submission of a protocol may be considered in certain circumstances.
The clinical study must focus on neuroblastoma, pediatric CNS tumors and/or sarcomas
Amount: $25,000 to $300,000 dependent on the scope of the proposal
Deadline for Clinical Idea of Intent: Continuous
For more info: http://solvingkidscancer.org/work/grants
January 15, 2012
Alliance for Lupus Research - Functional Genomics and Molecular Genetic Pathways in Systemic Lupus Erythematosus Grants
This program funds research grant and pilot grant applications. Research grants must provide evidence of preliminary data. Pilot grants are for projects that are not supported by preliminary data. Applications submitted should focus on two principal areas: (1) functional validation to determine which candidate genes/variants identified in human lupus have an authentic role in the disease and (2) detailed elucidation of the molecular pathways modulated by these candidate genes/variants identified in human lupus.
Amount: up to $175,000/ year for two years
Deadline: Feb 15, 2012
For more info: http://www.lupusresearch.org/research/grants.html
Aplastic Anemia & MDS International Foundation, Inc.
Topic areas considered for funding include
• promoting understanding of the etiology and pathogenesis of aplastic anemia, MDS, or PNH;
• improving symptom management and the quality of life for aplastic anemia, MDS, or PNH patients;
• discovering new treatments for aplastic anemia, MDS, or PNH; and
• understanding and preventing complications of bone marrow failure conditions (e.g., blood clotting/thrombosis in PNH, iron overload in MDS, etc).
Amount: $30,000/ year for up to two years
Deadline: Feb 29, 2012
For more info: http://www.aamds.org/2012-research-grant-guidelines
The focus of the foundation is on Huntington's disease. Support will be for research projects that will contribute to identifying and understanding the basic defect in Huntington's disease. Areas of interest include trinucleotide expansions, animal models, gene therapy, neurobiology and development of the basal ganglia, cell survival and death, and intercellular signaling in striatal neurons.
Amount: $50,000/one year, with possibility of renewal
Deadline: Oct 15, 2012
For more info: http://www.hdfoundation.org/funding/grants.php
International Development Research Centre
At IDRC, the Canadian Partnerships (CP) program’s Small Grants for Innovative Research and Knowledge- Sharing respond to requests from local, regional, national and international organizations based in Canada that are engaged in producing or sharing "research and knowledge for development".
Our aim is to improve Canadians’ understanding of global development issues that affect Canada and lower-income countries and increase the knowledge and skills to address them.
This call offers two types of funding:
1) Support to research, knowledge-building, and knowledge-sharing projects.
2) Support to events and to small dissemination activities and products.
Deadline: Feb 13, 2012
For more info: http://www.idrc.ca/EN/Programs/Canadian_Partnerships/Documents/Small-Grants-Call-Document-English_jan_2012.pdf
Leukemia Research Foundation, Inc. - New Investigator Research Grants
The Leukemia Research Foundation supports research on leukemia and related subjects. These New Investigator Research grants should be clearly identified as one year of pilot funding for new projects and should not be used for bridge funding of established laboratory investigators who are between larger grants. The foundation intends that its support should enable an investigator to initiate and develop a project sufficiently to obtain continuing funding from national agencies.
Eligibility for research grants is restricted to investigators who are within seven years of the end of their training or of their first independent faculty appointment at the time of the proposed starting date of the new investigator research grant award.
Amount: $100,000
Deadline: Feb 15, 2012
For more info: http://www.leukemia-research.org/NETCOMMUNITY/Page.aspx?pid=215&srcid=183
Orthopaedic Research and Education Foundation Prospective Clinical Research Grant in Spine Care
Spine surgeons who are board-certified in neurosurgery and/or orthopaedic surgery are invited to apply for grant support to further the work of individual investigators, investigator networks, single institutions, or consortia of institutions conducting prospective clinical research. Grants will in spine care in any of the following study areas:
• spinal deformity—adult deformity outcomes, spondylolisthesis, pediatric scoliosis, pediatric kyphosis, and early onset scoliosis;
• spine trauma—epidemiology, process and outcomes of spinal injuries, surgical treatment of acute spinal cord injury);
• degenerative spinal disorders—prospective outcomes for surgical and non-surgical treatments of lumbar, cervical, and thoracic degenerative spinal disorders;
• spinal oncology (epidemiology, process and outcomes of primary and metastatic spinal tumors);and
• non-surgical interventions for the treatment of spine injuries and disorders, including diagnostic, public health and rehabilitative methodologies.
Amount: $50,000-$100,000 per year for up to three years
Deadline: Mar 8, 2012
For more info: http://www.oref.org/site/PageServer?pagename=grants_homepage#crg
Prostate Cancer Foundation - Coalition to Cure Prostate Cancer (CCPC) 2012 Young Investigator Award Program
The Prostate Cancer Foundation has been contracted by the Coalition to Cure Prostate Cancer to administer the Coalition to Cure Prostate Cancer (CCPC) 2012 Young Investigator Award program. Consistent with CCPC's goal to end death and suffering from prostate cancer, these awards are focused on developing a gifted cohort of investigators to undertake the next generation of prostate cancer research.
An applicant should be within six-years following completion of a professional degree or clinical training such as MD, PhD, MD-PhD, MPH, or equivalent. An applicant may hold title of Senior Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent.
Amount: $75,000/year for 3 years
Deadline: Feb 29, 2012
For more info: http://www.pcf.org/site/c.leJRIROrEpH/b.5849007/k.F70A/Open_RFAs.htm
Prostate Cancer Foundation - PCF-Honorable A. David Mazzone Special Challenge Award Research Program
Challenge Awards support large-scale research projects. Proposals must be from teams of at least three highly experienced investigators capable of devoting unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several, located anywhere in the world.
These awards will focus on funding treatment sciences. Research with a high probability of near-term patient benefit is required in the following topic areas: translational research in metabolism/adiposity/nutrition/survivorship; molecular imaging in both primary and metastatic disease; co-targeting tumor microenvironment; first-in-field research on new targets in metastatic disease systemic treatment; mechanisms of resistance to new treatments for advanced prostate cancer; and diagnostics and biomarkers that differentiate indolent from metastatic prostate cancer.
Amount: $1 million over two years
Deadline: Mar 16, 2012
For more info: http://www.pcf.org/site/c.leJRIROrEpH/b.5849007/k.F70A/Open_RFAs.htm
Scleroderma Foundation - Established Investigator Grant
The foundation is seeking applications from promising established investigators both inside and outside the field of systemic sclerosis (SSc) research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative or highly relevant theme related to SSc. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.
Amount: up to $75,000 per year for up to two years
Deadline: Sep 15, 2012
For more info: http://www.scleroderma.org/research/estab_invest.shtm
Smith-Lemli-Opitz/RSH Foundation
Smith-Lemli-Opitz Syndrome (SLOS) is an autosomal recessive genetic disorder causing a defect in cholesterol synthesis which results in delays in all areas of development and may be complicated with one or more congenital malformations. SLOS is a life-long disorder with no cure and limited treatment options, and is often misunderstood. Many individuals with the syndrome go completely undiagnosed. It is a goal of the Smith-Lemli-Opitz/RSH Foundation to fund research that addresses these issues. Therefore the foundation seeks and accepts proposals for research into furthering any knowledge related to SLOS.
The foundation's main interest is in providing funding to experienced investigators for testing of initial hypotheses and preliminary data collection leading to long-term funding by major granting institutions (often considered "seed money"), and continuation of ongoing research while other funding is in the final stages of acceptance. However, as a secondary goal in the research arena, the Foundation wishes to continually attract new investigators into the realm of SLOS and welcomes any proposals they may put forth.
Amount: $25,000
Deadline: Feb 15, 2012
For more info: http://www.smithlemliopitz.org/index.php?option=com_content&view=article&id=72&Itemid=59
December 15, 2011
Alzheimer's Drug Discovery Foundation - Program to Accelerate Clinical Trials for Alzheimer's Disease
The true test for new Alzheimer's drugs is in human clinical trials. Over 150 potential treatments for Alzheimer's disease have been shown to be safe and to have some positive effect when tested in animal models of Alzheimer's disease. However, many of these potentially successful drugs have not been brought to human trials because of the increased cost and risk at this stage of research. The ADDF is responding to this problem by creating the Alzheimer's Program to Accelerate Clinical Trials (PACT). The goal of this Request for Proposals (RFP) is to increase the number of innovative drugs tested in humans for Alzheimer's disease. This program will fund biomarker-based pilot clinical trials for Alzheimer's disease.
Amount: up to $1,000,000
Deadlines: Jan 19, 2012; April 10, 2012; July 10, 2012; Oct 10, 2012. Submission of a letter of intent is required at least two weeks prior to the application deadline.
For more info: http://www.alzdiscovery.org/
AO Foundation - Start-up Grants
The AO Start-up Grant is funded by the AO Foundation. It has an independent review board and supports projects in a wide range of research fields within the broad goals of the AO Foundation including unconventional and novel projects. In particular it favors projects dealing with trauma, surgery of the loco-motor system, and related basic, clinical, pre-clinical and clinical research and projects broadly in the fields of general trauma, spine, cranio-maxillofacial and veterinary surgery. Its mission is to provide predominantly seed money and it has a bias towards researchers in the early part of their career.
This grant category is designed to encourage researchers to develop unconventional, novel projects and to expand in a wide range of research fields within the general areas of interest of the AO Foundation.
Amount: CHF 60,000/year for two years
Deadlines: Jan 16, 2012; July 16, 2012
For more info: http://www.aofoundation.org/research/research-funding/Pages/aorf-application-report-form.aspx
ASTRO Junior Faculty Career Research Training Award
This award was created to stimulate interest in radiation research early in junior faculty’s careers by offering them the opportunity to have focused time for research projects in radiation oncology, biology, physics or outcomes/health services.
Amount: $100,000 annually for two years
Deadline: Mar 29, 2012
For more info: https://www.astro.org/Research/Funding-Opportunities/ASTRO-Supported-Grants/Junior-Faculty/Index.aspx
The foundation provides grants to young Canadian scientist for the establishment of their research program, with a special emphasis on innovative proposals that have the potential to contribute to the understanding of fundamental mechanisms of disease processes or to contribute to their cure.
Applicants should be new Canadian investigators within the first three years of their first independent university or research institute appointment, receiving less than $100,000 in total start-up funds.
Amount: $20,000
Deadline: Mar 15, 2012
For more info: http://www.utoronto.ca/bantresf/Application/application_procedure.html
Canadian Child Health Clinician Scientist Program - Career Development Award
The CCHCSP supports highly qualified child health clinician candidates who wish to develop the requisite knowledge and skills for a career as an independent scientist in child health research. Trainees will engage in research training and a core curriculum in one of the participating Child Health Research Training Centres of the Canadian Child Health Clinician Scientist Program.
The Career Development Award is directed at clinician scientists who have completed doctoral level research training and who are newly appointed as a clinician scientist (within two years of completing their research training) based in one of the participating Child Health Research Training Centres of the Canadian Child Health Clinician Scientist Program. The award will facilitate guarantee of protected time during early career development within a mentored research program. A minimum of 75 percent time commitment to research is expected.
Deadlines: Apr 01, 2012; Nov 01, 2012
For more info: http://www.cchcsp.ca/training-paths/overview
Canadian Foundation for AIDS Research (CANFAR)
CANFAR was established to meet an urgent need for research on Acquired Immune Deficiency Syndrome (AIDS) and the conditions related to it, all of which are associated with an infection with the retrovirus HIV. To this end CANFAR awards research grants in the basic sciences, clinical, biological, epidemiological and psycho-social areas related to fundamental and applied research; education and prevention; psycho-social research; community research; and care.
Amount: $80,000 per year for a two-year period
Deadline: Feb 17, 2012
For more info: http://www.canfar.com/en_CA/p/canfar-research-grant-application
Children's Tumor Foundation - Drug Discovery Initiative Award
The Children's Tumor Foundation Drug Discovery Initiative Awards program supports early stage screening of candidate drug therapies for the treatment of neurofibromatosis (NF): NF1, NF2 and Schwannomatosis. DDI Awards is a catalyst program that has helped to fuel the drug pipeline with promising leads.
DDI Awards provides support for in vitro screens and in vivo screens to test efficacy of candidate NF therapies in cell and animal models. If in vitro screens yield promising data, awardees may apply for subsequent in vivo funding to continue the research.
Amount: DDI Awards are seed grants of $25,000 for in vitro screens, or $50,000 for in vivo screens (includes 10 percent indirect costs) of candidate NF therapeutics.
Deadlines: Feb 28, 2012; Aug 31, 2012
For more info: http://www.ctf.org/For-Scientists/drug-discovery-initiative.html
Crohn's and Colitis Foundation of Canada - Innovations in IBD Research
The CCFC invites applications for an Innovative Research Grant to fund novel or innovative approaches to inflammatory bowel disease (IBD) research. "Innovations in IBD" is intended to stimulate and support research that may not be encompassed within the boundaries of traditional medical research.
Amount: maximum of $50,000 for one year
Deadline: Mar 01, 2012; Sep 01, 2012
For more info: http://www.ccfc.ca/site/c.ajIRK4NLLhJ0E/b.6326399/k.4BD2/Opportunities_For_Researchers.htm#innovations
The mission of the Cystic Fibrosis Foundation (CFF) is to assure the development of the means to cure and control cystic fibrosis (CF) and to improve the quality of life for those with the disease. Research Grants are issued primarily for basic science research. This grant mechanism is intended to encourage the development of new information that contributes to the understanding of the basic etiology and pathogenesis of CF. Funding priority will be placed on those projects proposing to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat it. All proposals must be hypothesis driven, and sufficient preliminary data must be provided to justify CFF support. Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health (NIH). Those proposals that include methodologies requiring sampling of materials from human subjects will only be considered under this mechanism if the sampling method constitutes minimal patient risk (e.g., venipuncture) and patient samples or data are anonymous.
Amount: up to $90,000 per year, plus 8 percent indirect costs may be requested
Deadline for letter of intent: Apr 01, 2012
For more info: http://www.cff.org/research/ForResearchers/FundingOpportunities/ResearchGrants/
Juvenile Diabetes Research Foundation International - Beta Cell Therapies: The Formation of a Collaborative Consortium to Address Encapsulation for Beta Cell Replacement
JDRF is soliciting EOIs to encourage collaborations among bioengineers, chemists, immunologists, transplant researchers, and pancreatic beta cell biologists to incorporate engineering concepts and designs into current efforts toward improving islet encapsulation as a key component of cell replacement therapy for T1D. Ultimately, the funded projects should have established milestones and make progress toward making encapsulated human islets/porcine islets/hESC-derived pancreatic progenitors a translatable technology applicable in the clinical setting.
Amount: up to total $350,000 USD per year, for up to three years
Deadline for expression of interest: Mar 26, 2012
Deadline for application: Jun 18, 2012
For more info: http://www.jdrf.org/index.cfm?page_id=114027
Leukemia & Lymphoma Society - Translational Research Program
The Translational Research Program was established to encourage and provide support for new and novel clinical research. The goal of the program is to accelerate transfer of findings from the laboratory to clinical application. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life. A principal intent of the program is to permit the acquisition of sufficient data to apply to an appropriate agency or sponsor for sustained support.
The Translational Research Program (TRP) was developed to encourage and provide early-stage support for clinical research in leukemia, lymphoma and myeloma, which is intended to develop innovative approaches to treatment, diagnosis or prevention.
Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of leukemia, lymphoma and myeloma. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the clinical exploitation of the studies proposed and the results expected. This feature of the proposal will be an important consideration of the review process. While work directed at a further elucidation and understanding of the fundamental cellular and molecular biology of neoplastic lymphohematopoietic cells is a research priority of LLS, the Translational Research Program is specifically intended for the support of work which is clearly clinical in orientation.
Amount: maximum of $200,000/yr for 3 years
Deadline for letter of intent: Mar 01, 2012
Deadline for application: Mar 15, 2012
For more info: http://www.lls.org/#/researchershealthcareprofessionals/academicgrants/translationalresearch/
Office of the Privacy Commissioner of Canada
The Office of the Privacy Commissioner of Canada (OPC) has issued a call for proposals under its Contributions Program 2012-13. Established in 2004, the Contributions Program promotes the advancement of privacy knowledge in Canada by providing funding for independent privacy research and related knowledge translation initiatives in Canada under the Personal Information Protection and Electronic Documents Act (PIPEDA).
The OPC is interested in receiving research proposals for projects aimed at promoting privacy and the protection of personal information in the private sector. The Office invites proposals that focus on its four priority areas: 1) identity integrity and privacy; 2) information technology and privacy; 3) genetic information and privacy; and 4) public safety and privacy. However, the Office will consider proposals in other areas related to privacy and protection of personal information in the private sector.
Deadline: Jan 25, 2012.
For more info: http://www.priv.gc.ca/media/nr-c/2011/an_111208_e.cfm
Prostate Cancer Canada - Pilot Grant Program
This Request for Applications (RFA) is intended to support biological and clinical research projects that are Prostate Cancer specific/exclusive in nature.
Amount: maximum value of $150,000 over 2.5 years
Deadline: Mar 30, 2012
For more info: www.prostatecancer.ca
Kenneth Rainin Foundation - Innovator Awards Program for Inflammatory Bowel Disease
The Kenneth Rainin Foundation has announced its 2012 Innovator Awards Program for Inflammatory Bowel Disease. The program is intended to support innovative, "out-of-the-box" research projects that are potentially transformative in the effort to diagnose, treat, and/or cure IBD. The program seeks to encourage worldwide cooperation across all disciplines to uncover the cause of the disease and create opportunities for novel approaches and alternative options for treatment.
Deadline for letter of inquiry: Feb 15, 2012
For more info: http://www.krfoundation.org/
Rita Allen Foundation Award in Pain
The Rita Allen Foundation and the American Pain Society announce the 2012 Rita Allen Foundation Award in Pain. Request for applications is now open.
The RAF and APS announce the 2012 Award in Pain.
Proposed research projects should be directed towards the molecular biology of pain and/or basic science topics related to the development of new analgesics for the management of pain due to terminal illness.
Candidates should be in the early stages of their career with an appointment at faculty level.
Amount: $50,000 annually, for a period of up to three years
Deadline: Jan 17, 2012
For more info: http://www.ampainsoc.org/awards/rita_allen.htm
The SFA has developed a program to provide grants to investigators interested in translational science Sarcoma research. Funding is available in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human Sarcomas. In accordance with the mission of the Foundation, research involving the development of novel agents against Sarcoma, or research that could potentially lead to the development of novel agents against Sarcoma, is eligible for this funding. Preference will be given to proposals on promising molecular targets and new or uncommon therapeutic approaches. These approaches include, but are not limited to:
- Metabolic targets: c-Met, HDACs, WNT pathway signaling, rank ligand, IGF2; PI3 kinase, Akt, Hedgehog pathway (Ihh, Shh, Dhh), PARP, Notch, and Beta-catenin.
- Therapeutic classes applicable to Sarcoma: Immunotherapy, Metabolomics, miRNAs, Cytokines CCL2, and CCL3.
In compliance with IRS instructions, grants cannot fund clinical trials, but all other areas of research can be considered for funding.
Amount: up to $50,000
Deadline: Jan 31, 2012
For more info: http://www.curesarcoma.org/index.php/research_grants/
World Anti-Doping Agency Research Grant Program
WADA promotes and funds, on a yearly basis, scientific projects in the anti-doping field covering the development or optimization of analytical tools for the detection and/or quantification of doping substances or methods as well as the pharmacology of such substances and the ergogenic effects of specific substances/methods or group of substances on athletic performance. In this context, WADA gives high priority to projects with direct and imminent applicability in the fight against doping in sport and less preference to basic research projects.
Special attention will be given to projects addressing:
• autologous blood transfusion,
• detection of peptide hormones
• improvement of windows/limits of detection of prohibited drugs.
For 2012, submission of research projects covering the following topics is encouraged:
A. Detection of prohibited substances/methods: methodologies in analytical chemistry, and in particular research addressing:
B. Detection of prohibited substances/methods: affinity-binding and biochemical methodologies, and in particular research addressing:
C. Detection/Identification of novel doping trends, and in particular research addressing:
D. Pharmacological studies on doping substances/methods, and in particular research addressing:
Deadline: Feb 17, 2012
For more info: http://www.wada-ama.org/en/Science-Medicine/Research/Applying-for-Research-Grants/
November 30, 2011
Akira Arimura Foundation Research Grant Program
The Akira Arimura Foundation seeks proposals for its 2012 PACAP Research Award Program for research on therapeutics applications for Pituitary Adenylate Cyclase- Activating Polypeptide (PACAP). The Foundation aims to provide awards that may complement existing actively funded programs in the laboratory of the investigator or mentor to allow the translational research by young investigators (generally within 5 years of having received his/her doctorate or equivalent) working at an academic, not-for-profit institution under the supervision of a research mentor in the field.
Amount: up to $50,000 for one year
Deadline: Dec 10, 2011
For more info: http://www.brain.tau.ac.il/vip-pacap2011/award_young.html
Anesthesia Patient Safety Foundation - Patient Safety Career Development Award Program
The Anesthesia Patient Safety Foundation (APSF) is soliciting applications for training grants to develop the next generation of patient safety scientists. In this initial, proof-of-concept RFA, APSF intends to fund one Patient Safety Career Development Award (PSCDA) to the sponsoring institution of a highly promising new patient safety scientist.
Amount: up to $75,000 per year for a period of 2 years
Deadline: Dec 31, 2011
For more information: http://www.apsf.org/announcements.php?id=8
CNIB Baker Applied Research Fund
The CNIB Baker Applied Research Fund supports research that is focused on the social, educational, cultural and rehabilitative needs of Canadians living with vision loss, and the application of assistive devices to meet these needs. This program is intended both to advance the career development of new investigators, and to encourage senior researchers to develop programs of applied research.
Amount: $35,000
Deadline: Jan 15, 2012
For more info: http://www.cnib.ca/en/research/funding/eabaker-applied/
IOF-Servier Young Investigator Research Grant
The IOF-Servier Young Investigator Research Grant aims specifically at encouraging young scientists to carry out high quality research. The grant is generously supported by the Servier Research group in partnership with IOF, and awards Euro 40,000 towards original research of significant value and international relevance in the field of osteoporosis. Consistent with IOF's objectives, the project must contribute to ensuring that osteoporosis sufferers receive the best care possible.
Amount: Euro 40,000
Deadline: Dec 31, 2011
Lymphatic Malformation Research Opportunity
Liam’s Land Organization awards grants to applicants who seek to conduct research to find the cause, treatment, or cure for lymphatic malformation (also known in the past as cystic hygroma or lymphangioma).
Amount: up to $25,000 annually for up to 2 years
Deadline: Feb 05, 2012
For more info: http://www.liamsland.org/liams-land-medical-reseach-grants/
Medical Council of Canada - Fund for Research in Clinical Assessment
The purpose of the competition is to encourage innovation in the assessment of clinical competence or performance of students, postgraduate trainees, or practitioners. The steering committee will give priority to proposals that show promise in contributing to the knowledge and understanding of measurement in clinical assessment and to clinical program evaluation methods for medical education. The proposal must focus on research, not development, in the assessment of performance or clinical assessment.
Amount: maximum of $37,500
Deadline: Feb 01, 2012
For more info: http://www.mcc.ca/en/research/grants_apply_one_year.shtml
NSERC - Idea to Innovation (I2I) Program
The objective of the Idea to Innovation (I2I) program is to accelerate the pre-competitive development of promising technology originating from the university sector and promote its transfer to a new or established Canadian company. The program provides funding to college and university faculty members to support research and development projects with recognized technology transfer potential. This is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.
Eligible research and development activities include (but are not limited to) the following:
- Refining and implementing designs
- Verifying application
- Conducting field studies
- Preparing demonstrations
- Building engineering prototypes
- Performing beta trials
Eligible technology transfer activities include (but are not limited to) the following:
- Market studies
- Consulting fees (for business plan, market survey)
- Patenting expenses (see limitations in program guidelines)
- Expenses associated with creating a partnership (travel)
Deadlines: Jan 09, 2012; Apr 10, 2012; Jul 03, 2012; Oct 01, 2012
For more info: http://www.nserc-crsng.gc.ca/Professors-Professeurs/RPP-PP/I2I-INNOV_eng.asp
North American Spine Society - Research Grants
General North American Spine Society (NASS) research grants provide funding for promising research projects by qualified investigators in the field of spine. NASS supports basic, clinical and translational science performed with integrity. The goal is to improve quality spine care for patients and understanding of underlying disorders. Any spine-related proposal will be considered. Funds are for work to be performed or works in progress, not works already completed. NASS does not support research for independent manufacturers, industry development or personal business financial gain.
Amount: up to $50,000/year
Deadline for Letter of Proposal: Feb 06, 2012
For more info: http://www.spine.org/Pages/PracticePolicy/Research/ResearchFunding/GrantsAwards/Default.aspx
Ontario HIV Treatment Network - Research Operating Grant
The OHTN Research Operating Grant was developed to help realize the mission of the OHTN – to improve the health and well-being of people living with and at risk of HIV in Ontario through a network that promotes research and evidence to drive change. This will be accomplished by funding research that: a) is relevant to one or more of the populations most affected by HIV in Ontario (people living with HIV, gay men and other men who have sex with men, African, Caribbean and Black men and women, Aboriginal men and women, men and women who use drugs, and women who have unprotected sex or share drug equipment with people from these populations); b) has the potential to have a measurable impact in the short to medium term (i.e., in the next 2 to 5 years); and c) is scientifically rigorous.
Amount: up to $125,000 per year for up to 3 years
Deadline: Jan 06, 2012
For more info: http://www.ohtn.on.ca/Documents/Funding/2011/FINAL_Guidelines_OHTN_ROG.pdf
November 15, 2011
Alzheimer Society of Canada - Young Investigator Grants Program
Young Investigator (YI) Grants are prestigious funding opportunities designed to help launch the careers of outstanding young researchers who are entering their first phase of an academic appointment. The intent is to help the grantee establish his or her laboratory and generate enough preliminary data to support full research grant proposals in national funding competitions. Proposals are invited in all areas of biomedical and quality of life research that are relevant to Alzheimer's disease and related dementias.
Applicants must be within two years of their first university appointment at the application deadline date, and documentation must be provided from the institution to show that the applicant has been appointed to a salaried position that will continue for the duration of the grant. An application for a Young Investigator Grant may not include co-applicants.
Deadline: Nov 21, 2011
For more info: http://www.alzheimer.ca/english/research/resprog-intro.htm
American Brain Tumor Association Translational Grant
An American Brain Tumor Association Translational Grant is for pre-clinical research that critically evaluates the diagnostic and/or therapeutic potential of recent discoveries for advancement to clinical application. Human studies and basic science studies not at the translational phase are excluded from consideration.
Eligibility: As of July 1, 2012, MDs must be within eight years of completion of their post-residency training, and hold a Faculty or Junior Faculty appointment. PhDs must be within three to ten years of having received their doctorate, and hold a Faculty or Junior Faculty appointment.
Amount: $75,000
Deadline: Jan 10, 2012
For more info: http://www.abta.org/index.cfm?contentid=304&research-grants-fellowships
California Table Grape Commission 2012 Health Research Grants
The California Table Grape Commission is pleased to announce its request for Letters of Intent to submit a proposal for its 2012-13 Health Research Grant Program.
The major goal of this program is to fund studies that examine the potential health benefits of grape consumption.
Amount: $30,000
Deadline for letters of intent: Nov 21, 2011
For more info: http://www.grapesfromcalifornia.com/healthresearchgrants.php
The CDA offers support for research projects designed to enhance our knowledge of the prevention, etiology, management and cure of diabetes and related complications, as well as population health, health services, diabetes education, community and practice-based research.
Amount: maximum of $100,000 annually for a period of up to three years
Deadline for Registration: Dec 01, 2011
Deadline for Applications: Feb 01, 2012
For more info: http://www.diabetes.ca/for-professionals/research/2012-competition/
Canadian Foundation for Women's Health - General Research Grants
The CFWH General Research Grants are awarded to those committed to finding solutions to the reproductive health issues that face women both in Canada and around the world. The grants are open to any area within the field of obstetrics and gynaecology, these grants aim to help make further advancements in women's health treatment, research, and education. To be eligible for all available funding, applicants must be an Society of Obstetricians and Gynaecologists of Canada member in good standing.
Deadline: Feb 15, 2012
For more info: http://cfwh.org/index.php?page=grant-information&hl=en_CA
Cerebral Palsy International Research Foundation
The Foundation provides funding for pilot studies on research important to the prevention and treatment of cerebral palsy, including improvement in the quality of life of persons with disabilities due to cerebral palsy and closely related developmental brain disorders. This broad research agenda includes basic, clinical and applied research in the biomedical and bioengineering sciences.
Amount: maximum of $50,000 a year for up to 2 years
Deadline for Letter of Intent: Continuous
For more info: http://www.cpirf.org/research/grant-applications
Gates Foundation - Grand Challenges in Global Health Grants
The Grand Challenges in Global Health initiative is focused on engaging creative minds to work on scientific and technological breakthroughs for the world’s most pressing health problems. Grand Challenges Explorations is a grant program within the initiative that fosters innovative, early-stage research to expand the pipeline of ideas that can lead to those much needed global health and development solutions. A total of $44 million in funding is available to expand the pipeline of ideas to help women and children live more prosperous and healthy lives in the developing world.
Preventing Preterm Birth: In coordination with the Global Alliance to Prevent Prematurity and Stillbirth, this initiative seeks to generate new discoveries for more rapid development of equitable, relevant, and innovative interventions to prevent preterm birth and stillbirth. By filling the void of scientific knowledge on the causes and mechanisms important to preterm birth in the developing world, the initiative hopes to identify low-cost novel technologies that reduce the global burden of prematurity; attract scientists to engage in this underserved global health field; and increase investments from other global health research and development funders. The initiative expects to fund a diverse group of investigators with skills and innovative approaches who ultimately will work together to interrogate hypotheses using state-of-the-art model systems. The competition expects to award a total of up to $20 million in six to ten grants of up to $2 million each for a three- to four-year period. (Deadline: January 31, 2012.)
Discover New Ways to Achieve Healthy Growth: The goal of this opportunity is to elucidate new pathways or mechanisms that directly inform the development of interventions for the prevention of impaired growth (i.e., stunting and wasting, during the first thousand days following conception). Ultimately, the program seeks to identify simpler, less costly, and more effective interventions delivered before conception, during pregnancy, or in the first two years of life. Approaches should address the underlying biological mechanisms that lead to adverse developmental outcomes, focusing specifically on either or both infection and nutrition, the two primary factors involved in altering the course of fetal and infant growth and development in the developing world. The competition will award up to a total of $15 million in grants of up to $2 million each for a period of thirty-six to forty-eight months. (Deadline: January 25, 2012.)
Biomarkers of Gastrointestinal (Gut) Function and Health: The goal of this opportunity is to identify and validate biomarkers of gut function to improve the health and development of children in the developing world. The competition is intended to identify a promising biomarker or a biomarker signature that accurately reflects physical and physiological properties of the structural and/or functional integrity of the gut, especially the ileum or small intestine. The program seeks new ideas and potential collaborations from academic, industrial, and other expert investigators for the discovery and validation of biomarkers or biomarker signatures that are indicative of a healthy, functional, or injured GI tract in order to facilitate the future development of robust diagnostic tests for use in pediatric populations in low-resource settings. Up to a total of $9 million is available in awards of up to $1.5 million for project periods of no longer than twenty-four months. (Deadline: January 11, 2012.)
For more info: http://www.gatesfoundation.org/global-health/Pages/grand-challenges-explorations.aspx
GE Open Innovation Cancer Research Funding Initiative
GE has launched a global initiative to accelerate early detection of cancer and enable more personalized treatment. Ideas will be considered for seed awards ($100,000 funding) and commercial investment (up to $100 million in capital funds from GE and its VC partners may be invested globally into promising start-ups and ideas)
Deadline: Nov 20, 2011
For more info: www.healthymagination.com
International Association for the Study of Pain
The IASP Collaborative Research Grants support international, interdisciplinary collaborations in pain research. The principal investigator in charge of the overall project must be a member of IASP of at least one year’s standing.
Amount: $15,000
Deadline: Mar 15, 2012
For more info: http://www.iasp-pain.org/
James S. McDonnell Foundation Research Awards for Brain Cancer Research
All proposals submitted to the foundation must clearly link the experimental models and questions to the realities of human disease. Proposals primarily intending to characterize basic mechanisms of growth and development that may plausibly but are not yet known to be contributory to human brain cancer are not encouraged. Proposals testing molecules as possible treatment interventions should consider including tests designed to uncover unintended biological effects of such molecules that would disqualify future clinical usefulness. Research with in vitro or in vivo model systems must demonstrate that the model has predictive value for human tumors.
The Foundation is particularly interested in supporting novel research that will generate new knowledge leading to increased rates of survival and improve functional recovery for individuals with brain cancer.
Amount: up to $450,000 for up to 6 years
Deadline: Mar 14, 2012
For more info: http://www.jsmf.org/apply/
James S. McDonnell Foundation Scholar Awards in Complex Systems Science
The Complex Systems program supports scholarship and research directed toward the development of theoretical and mathematical tools that can be applied to the study of complex, adaptive, nonlinear systems. It is anticipated that research funded in this program will address issues in fields such as biology, biodiversity, climate, demography, epidemiology, technological change, economic development, governance, or computation. JSMF supports research in the brain sciences through its topical program Understanding Human Cognition. The Foundation recommends that researchers in the neurosciences not submit proposals to the Complex Systems RFA. Typically, such proposals are unsuccessful. While the program's emphasis is on the development and application of the theory and tools used in the study of complex research questions and not on particular fields of research per se, JSMF is particularly interested in projects attempting to apply complex systems approaches to coherently articulated questions. Proposals intending to apply complex system tools and models to problems where such approaches are not yet considered usual or mainstream are appropriate to the RFA.
Amount: up to $450,000 for up to 6 years
Deadline: Mar 14, 2012
For more info: http://www.jsmf.org/programs/cs/index.htm
National Headache Foundation Research Grant Program
The National Headache Foundation is interested in research protocols that are objectively sound and whose results can, when published in the medical literature, contribute to a better understanding and treatment of headache and pain.
Amount: maximum of $100,000
Deadline: Feb 01, 2012
For more info: http://www.headaches.org/For_Professionals/Research_Grants
The Society awards grants for research on rosacea. Because the etiology of rosacea is unknown, high priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition. Studies may also be funded in such areas as epidemiology, predisposition, quality of life and associations with environmental and lifestyle factors.
Amount: $10,000
Deadline: Apr 16, 2012
For more info: http://www.rosacea.org/grants/application.php
Parkinson Society Canada has the following opportunities:
- Pilot Project Grants
- New Investigator Award Grant
- Basic Research Fellowship
Deadline: Feb 01, 2012
For more info: http://www.parkinson.ca/site/c.kgLNIWODKpF/b.5158907/k.95C2/Applications.htm
The primary goal of awarding grants through the Research Fund is to support projects that offer a high likelihood of improving the understanding of pulmonary fibrosis in the following areas:
- Basic Science
- Translational Research
- Clinical Medicine/Research
- Social Science/Quality of Life
The Foundation offers Established Investigator Awards and Young Investigator Awards.
Established Investigator Awards are given to established investigators to explore innovative areas of research that may not yet be eligible for a NIH (or similar) grant.
Young Investigator Awards were established to provide research opportunities to promising and talented young investigators. Successful projects should eventually lead to independent research, thus making investigators competitive for major awards from the NIH, other federal agencies, private foundations, or other sources.
Amount: $50,000 over 2 years
Deadline for Letter of Intent: Nov 17, 2011
For more info: http://pulmonaryfibrosis.org/research/PFFGrants
October 31, 2011
Alcoholic Beverage Medical Research Foundation
The aim of the grant program is to energize the field by helping researchers begin their careers, and position them to attract greater alcohol funding from other sources with the track record resulting from a Foundation grant. The Foundation accepts applications for grants to conduct research on important aspects of alcohol consumption and its effects. Overall, the following areas are more directly related to the mission of the Foundation, and therefore, are of greater interest:
1. Factors influencing transitions in drinking patterns and behavior
2. Effects of moderate use of alcohol on health and well-being
3. Mechanisms underlying the behavioral and biomedical effects of alcohol
4. Biobehavioral/interdisciplinary research on the etiology of alcohol misuse.
The Foundation does not encourage applications on treatment of the complications of advanced alcoholism. However, research involving treatment intended to elucidate the pathogenesis of alcohol-related problems will be considered.
Amount: $50,000
Deadlines: Feb 01, 2012; Sep 01, 2012
For more info: http://www.abmrf.org/grant_program.asp
The ALS Association Research Investigator-Initiated Research Grant Program supports INNOVATIVE research of high scientific merit and relevance to amyotrophic lateral sclerosis (ALS). The research mission of the ALS Association is directing, encouraging, identifying, funding and monitoring relevant and cutting-edge research into the cause, treatment, prevention and cure for ALS. Multi-year Grants applications require strong preliminary data.
Amount: $80,000
Deadline for abstracts: Jan 06, 2012
For more info: http://www.alsa.org/research/program.cfm
The Regular Grants Program is designed to support Canadian investigators or small groups of investigators in conducting biomedical research into causes, prevention, diagnosis, treatment, and management of Alzheimer disease. The most favoured applications in the Regular Grants program are those which (a) focus on challenging new directions in research into Alzheimer's disease and related dementias, directions that are less likely to be funded by national funding agencies, perhaps because of insufficient preliminary data or the unorthodoxy of the research rationale or approach, and/or (b) are submitted by established researchers in fields not usually associated with Alzheimer's disease and related dementias research, who are proposing to apply their special approaches and techniques to novel projects clearly relevant to Alzheimer's disease and related dementias.
Deadline: Nov 21, 2011
For more info: http://www.alzheimer.ca/english/research/resprog-intro.htm
Alzheimer's Association - International Research Grant Program
The Investigator-Initiated Research Grant (IIRG) forms the backbone of the Alzheimer's Association International Research Grant Program. To be considered responsive, the research grant application must address a question or questions relevant to the 2012 areas of focus (listed below) or a compelling issue in Alzheimer research pertinent to the applicant's special interest or expertise.
Areas of focus are high-priority research areas in which the Association actively seeks proposals. The areas are defined broadly, and the examples cited are not intended to preclude or constrain other investigator-initiated projects or proposals. Potential applicants are strongly encouraged to submit proposals in their own areas of interest or formulate questions different from those presented in this announcement. Investigator-initiated research projects are the core of the Association's scientific program. The areas of focus for the 2012 International Research Grant Program are (1) Research in Diverse Populations: Closing the Gap; (2) Social or Behavioral and Cognitive or Functional Focus: Evaluating Interventions and Translating Knowledge into Practice; and (3) Biological Focus: Causes, Early Detection, Treatment, Models, Prevention and Risk Factors.
Amount: $240,000 for up to 3 years
Deadline for letter of intent: Dec 20, 2011
For more info: http://www.alz.org/research/alzheimers_grants/types_of_grants.asp
American Otological Society - Clinical Investigations Research Grants
The American Otological Society, Inc., through its Research Fund, supports clinical investigative research that is focused on the study of otosclerosis or Ménière’s disease. A description of the relationship between the research study and otosclerosis or Ménière’s disease is an integral part of the application. The Research Fund Advisory Board will review applications that propose, as a central focus, a clinical trial or other “hands on” patient clinical investigative study. Applicants should follow general guidelines for research proposals and also include information about the clinical study design and ethical requirements regarding human research subject participation.
The AOS places special value in translational research proposals that lead to and develop unique and innovative solutions to the clinical problems of people with Otosclerosis or Ménière's Disease. This funding mechanism is intended to support early-stage clinical trials to test novel therapeutic approaches as well as non-interventional patient oriented studies that are intended to lead to the development of clinical interventions and monitoring tools.
Amount: maximum of $66,000
Deadline: Jan 31, 2012
For more info: http://www.americanotologicalsociety.org/information.html
Anesthesia Patient Safety Foundation - Patient Safety Career Development Award
The Anesthesia Patient Safety Foundation (APSF) is soliciting applications for training grants to develop the next generation of patient safety scientists. In this initial, proof-of-concept RFA, we intend to fund one Patient Safety Career Development Award (PSCDA) to the sponsoring institution of a highly promising new patient safety scientist. In the future, APSF intends to fund one new PSCDA career development grant each year.
Amount: $75,000/year for two years
Deadline: Dec 31, 2011
For more info: http://www.apsf.org/announcements.php?id=8
Brain Tumor Foundation of Canada
Brain Tumour Foundation of Canda is seeking outstanding young researchers conducting quality brain tumour research. All such proposals will be given serious consideration, including pediatric brain tumour research and quality of life research. Additionally, the sponsor is interested in receiving innovative research proposals - those that incorporate novel or original concepts that have the potential to make a difference.
Applications will be considered for Basic, Clinical or Translational Research and all research focuses will be given serious consideration, including pediatric brain tumours.
Amount: $25,000
Deadline: Jan 13, 2012
For more info: http://www.braintumour.ca/173/research-grant-program
Juvenile Diabetes Research Foundation International - Beta Cell Therapies: Targeting Beta Cell Neogenesis and Transdifferentiation to Restore Functional Beta Cell Mass
The purpose of this call is to invite applications from single investigators or groups of investigators to identify and characterize cellular targets and mechanisms to promote beta cell neurogenesis and transdifferentiation for regenerative therapies for the treatment of insulin-dependent diabetes.
Amount: $100,000 - $250,000
Deadline for letter of intent: Nov 28, 2011
For more info: http://www.jdrf.org/index.cfm?page_id=114356
Klarman Family Foundation Grants Program in Eating Disorders Research
The Klarman Family Foundation is interested in providing strategic investment in translational research that will accelerate progress in developing effective treatments for anorexia nervosa, bulimia nervosa and binge eating disorder. The Program's short-term goal is to support the most outstanding science and expand the pool of scientists whose research explores the basic biology of eating disorders. The long-term goal is to improve the lives of patients suffering from these conditions.
Examples of funding areas include but are not limited to molecular genetic analysis of relevant neural circuit assembly and function; epigenetic research; animal models created by genetically altering neural circuits; and testing of new chemical entities that might be used in animal models as exploratory treatments. Please note that imaging studies involving humans are not eligible.
Investigators conducting research in the neuro-circuitry of fear conditioning or reward behavior may also apply but must justify the relevance of their research projects to the basic biology of eating disorders. Clinical psychotherapeutic studies, medication trials and research in the medical complications of these disorders are outside the scope of this Program.
Deadline: Feb 01, 2012
For more info: http://hria.org/tmfservices/tmfgrants/klarman.html
Potts Memorial Foundation Grant
The foundation provides funds for the care, treatment, and rehabilitation of persons afflicted with tuberculosis. Support may include maintenance operations of hospitals; research; vocational counseling and guidance; grants to hospitals and charitable institutions; and the operation of sheltered workshops. Today's focus is only on lung, tuberculosis, blood oxygen research, and/or equipment.
Deadlines: Apr 15, 2012; Sep 15, 2011
For more info: http://www.snpo.org/publications/fundingalert_details.php?m=7&y=2009&id=1332
Pulmonary Fibrosis Foundation Research Fund to Cure Pulmonary Fibrosis Grants Program
One of the primary goals of the Pulmonary Fibrosis Foundation is to fund research that will ultimately lead to successful therapies for Pulmonary Fibrosis (PF).
The Research Fund to Cure Pulmonary Fibrosis was established with the primary goal of funding innovative grants that offer a high likelihood of advancing research that could translate into successful therapies.
Deadline for Letters of Intent: Nov 17, 2011
For more info: http://pulmonaryfibrosis.org/research/PFFGrant
Restless Legs Syndrome Foundation
The RLS Foundation encourages grant applications for basic and clinical research studies of restless legs syndrome (RLS). Basic science leading to a better understanding of RLS, innovative approaches, interdisciplinary studies, and support of promising postdoctoral candidates is given funding priority.
Deadline for Letter of Intent: Dec 01, 2011
For more info: http://www.rls.org/Page.aspx?pid=539
Research grants are available to clinicians or established scientists working on epilepsy or related subjects.
Grants may be awarded for the following purposes:
1. Launching of a project (operating costs in the expectation of funds already requested from government agencies)
2. Pre-research (preliminary studies in preparation of a more substantial request to be addressed to another agency)
3. Pursuit or completion of a project (temporary support following the interruption or the termination of a grant)
4. Contribution to the funding of a research project of particular interest in the field of epilepsy
5. Contribution to the funding of a scientific activity (e.g., publication, meeting) related to the field of epilepsy
Amount: $25,000
Deadline: Jan 15, 2012
For more info: http://www.savoy-foundation.ca/eng/mission/defaut.htm
Simons Foundation Autism Research Initiative - Explorer Awards
The Simons Foundation Autism Research Initiative (SFARI) seeks to improve the diagnosis and treatment of autism spectrum disorders by funding, catalyzing and driving innovative research of the greatest quality and relevance. Although SFARI's immediate priority is to benefit individuals challenged by autism spectrum disorders, autism research is expected to yield insights into the neural mechanisms of fundamental human capabilities. Thus SFARI's efforts will aid the broader mission of the Simons Foundation to advance research in basic science and mathematics.
This new award program is designed to enhance SFARI's existing support of autism research by providing timely resources to enable focused experiments highly relevant to the initiative's mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.
Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high risk/high impact proposals are encouraged. We especially encourage applications from junior and senior investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.
Amount: $50,000
Deadline: Continuous
For more info: http://sfari.org/funding/grants/explorer-rfa
The Thrasher Research Fund remains open to a variety of pediatric medical research topics. Research projects with the potential to impact a large number of children as well as research projects that address severe problems affecting relatively few children will be considered. The fund seeks to maintain a portfolio of grants with a balance of both domestic and international research.
The fund supports clinical/translational pediatric research. Emphasis is placed on projects with potential findings that would be clinically applicable in a relatively short period of time for the prevention, diagnosis or treatment of pediatric medical problems.
Deadline: Continuous
For more info: http://www.thrasherresearch.org/sites/www_thrasherresearch_org/Default.aspx?page=37
UICC Yamagiwa-Yoshida Memorial International Cancer Study Grants (YY Grants)
The YY grant provides an important opportunity to advance cancer research through international collaboration. Their purpose is to enable cancer investigators from any country to carry out bilateral research projects abroad which exploit complementary materials or skills, including advanced training in experimental methods or special techniques.The research plan must consist of basic, translational or applied cancer research. Prevention-oriented projects are especially encouraged.
The grant's purposes are:
- to initiate, set up or pursue bilateral cancer research projects with collaborating investigators abroad
- to exchange and exploit complementary skills and material
- to receive training in advanced experimental research methods and techniques.
Amount: $10,000
Deadlines: Jan 15, 2012; Jul 01, 2012
For more info: http://www.uicc.org/fellowships/study-grants
U.S. Army Medical Research and Materiel Command - Medical Practice Initiative Breadth of Medical Practice and Disease Frequency Exposure
The intent and desired outcome of the research activities described in this program announcement are to conduct research concerning outpatient primary care physician skill degradation through testing and surveys of physicians compared with frequency of exposure to various diagnoses and presentations. The testing will be an assessment of physicians' knowledge, competence, fluency, and comfort with said conditions. The method to determine frequency of exposure must be based upon data extracted by Electronic Health Records that the investigators' study group has generated. The primary, but not exclusive, purpose of this program announcement is to solicit pre-proposals and then by invitation only, request full proposal submissions for research that will achieve the following:
1. Identify when and why degradation of cognitive clinical skills occurs. Cognitive skills may also include physician comfort and fluency with potential conditions and treatments such as generating interview questions, understanding the differential diagnosis for the complaint and selection of optimal therapies.
2. Create validated analytical tools that can predict the probable onset of cognitive skills degradation and determine, with specificity, when skill or knowledge areas have degraded or will be likely to degrade.
3. Propose methods and tools which will enable physicians to preemptively refresh knowledge and maintain familiarity and fluency across the expected competencies for their specialty. Determine optimal and minimal refreshment intervals to accomplish this goal. Identify impact of varying types of refreshment activities.
Deadline for preliminary proposal: Dec 22, 2011
For more info: http://www.grants.gov/search/search.do?mode=VIEW&oppId=127853
October 15, 2011
American Asthma Foundation
The American Asthma Foundation has announced its 2012 Research Award Program. Awards will be given at two levels:
• Early Excellence Awards
• Senior Investigator Awards
Deadline: Feb 08, 2012
For more info: http://www.americanasthmafoundation.org/grants/
Canadian Cancer Society Research Institute - Impact Grants
Impact grants have been created to support large, well-developed programs in cancer research that have the potential to make a significant impact on the burden of disease in patients and populations. Canada's research community is particularly strong in basic biomedical and translational science, and there has been a recent explosion of new understanding about cell structure and function and the disease process, thanks to significant advances in genetics, genomics, imaging, and many other fields. The goal of the CCSRI Impact grant program is to provide a mechanism for scientists to adopt innovations and accelerate the application of new knowledge to address problems in cancer research that have the potential for practical application to people by reducing cancer incidence, reducing cancer mortality or improving patient quality of life.
The purpose of this funding initiative is to support significant advancement of promising research ideas which have the potential to have a major impact on cancer. Although this grant program is primarily designed to support the biomedical/translational (End 2) research community, applications from all areas and disciplines of cancer research will be considered eligible for funding and will be evaluated based on a common set of criteria. Applicants are required to submit proposals for studies that explicitly address the Society's mission to eradicate cancer and enhance the quality of life of people living with cancer.
Amount: up to $250,000 per year and a maximum of $1,250,000 per grant.
Deadline for Letter of Intent: Feb 01, 2012
For more info: http://www.cancer.ca/research/Grants%20and%20Awards/Current%20funding%20opportunities/Impact%20grants.aspx?sc_lang=en
Canadian Cancer Society Research Institute - Innovation Grants
Innovation grants have been created to support innovative, creative problem solving in cancer research. As competition for grant funding increases, peer review panels become more conservative and risk averse, emphasizing feasibility more than innovation. The goal of this new CCSRI grant program is to support unconventional concepts, approaches or methodologies to address problems in cancer research. Innovation projects will include elements of creativity, curiosity, investigation, exploration and opportunity. Successful projects may be based on "high risk" ideas, but will have the potential for "high reward" (i.e. to significantly impact our understanding of cancer and generate new approaches to combat the disease by introducing novel ideas into use or practice).
Amount: up to $100,000 per year and a maximum of $200,000 per grant
Deadline for abstract registration: Feb 15, 2012
For more info: http://www.cancer.ca/research/Grants%20and%20Awards/Current%20funding%20opportunities/Innovation%20grants.aspx?sc_lang=en
Canadian National Institute for the Blind - CNIB Barbara Tuck MacPhee Award (Barbara Tuck MacPhee Family Vision Research Award in Macular Degeneration)
This award supports researchers in the field of macular degeneration. Research must be conducted primarily in Canada.
Amount: up to $35,000
Deadline: Jan 15, 2012
For more info: http://www.cnib.ca/en/research/funding/tuck-macphee/
Crohn's and Colitis Foundation of America Senior Research Awards
Objective: To provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources, such as the National Institute of Health (NIH). Proposal MUST be relevant to inflammatory bowel disease (Crohn's Disease or ulcerative colitis).
Deadline for letter of intent: May 1, 2012
For more info: http://www.ccfa.org/ccfaprof/sra/index.html
Focused Ultrasound Surgery Foundation Research Awards
The Foundation’s Research Awards Program provides seed funding for investigator-initiated projects involving MR-guided focused ultrasound. Preference is given to preclinical research projects and pilot clinical trials with the greatest potential to advance new therapeutic uses of this innovative technology.
Amount: up to $100,000 for one year
Deadlines: July 1, October 1, January 3, April 1
For more info: http://www.fusfoundation.org/Research-Program/information-for-applicants
Foundation Fighting Blindness - Individual Investigator Research Grants
Individual Investigator Research Grant Awards are designed to concentrate research in areas that will have the greatest potential to move towards treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration (dAMD). N.B.: FFB does not support research for neovascular AMD or diabetic retinopathy. The Foundation has identified research priority areas that align with its mission. The FFB will also consider proposals for highly novel research that does not fit easily within these goals or overlaps across goals. The LOI for such a proposal must clearly explain why the research is likely to lead to prevention, treatments or cures.
Amount: maximum of $100,000/year
Deadline: Oct 31, 2011
For more info: http://www.blindness.org/index.php?option=com_content&view=article&id=945&Itemid=273#cra
Foundation for Prader-Willi Research
The Foundation is accepting applications that address one of three challenging questions:
- Question 1: What underlies the shift from failure to thrive to excessive hunger in PWS?
- Question 2: Can the maternally silent genes in the PWS chromosome region be selectively reactivated?
- Question 3: What are the cellular phenotype(s) of PWS?
Deadline: Nov 15, 2011
For more info: http://www.fpwr.org/request-applications-2011
FRAXA's grants and fellowships program aims to encourage research aimed at finding a specific treatment for fragile X syndrome. FRAXA's goal is to bring practical treatment into current medical practice as quickly as possible; therefore, preference will be given to research projects that have a clear practical application and the results of which will be shared in a timely fashion.
Amount: up to $100,000/year
Deadline: Feb 1, 2012
For more info: http://www.fraxa.org/applyinggrants.aspx
Grand Challenges in Global Health – Round 8
Grand Challenges Explorations is a unique initiative that supports innovative research of unorthodox ideas. Every aspect of the program, including the carefully designed topics describing critical scientific barriers to progress in global health, the two-page online application, and the rapid review process, are designed to swiftly award funding to scientists who are testing unproven ideas that could lead to breakthroughs in global health.
Topics for Grand Challenges Explorations Round 8 are:
• Protect Crop Plants from Biotic Stresses From Field to Market
• Design New Approaches to Optimize Immunization Systems
• Explore New Solutions for Global Health Priority Areas
• Explore Nutrition for Healthy Growth of Infants and Children
• Apply Synthetic Biology to Global Health Challenges
Amount: Initial grants of $100,000 are awarded two times a year. Successful projects have the opportunity to receive a follow-on grant of up to $1 million.
Deadline: Nov 17, 2011
For more info: http://www.grandchallenges.org/Explorations/Pages/ApplicationInstructions.aspx
Lloyd Charitable Trust, Harry J.
Applications will be accepted for a broad range of melanoma research projects involving basic science, clinical trials, etc. Special consideration will be given in two areas: (1) emerging novel concepts that constitute significant innovation and (2) new investigators in the field of melanoma. Programs include:
- Career Development Grants: These grants are intended to be used for salary support for promising young melanoma investigators (M.D. or Ph.D.).
- Basic Research Grants: These grants are intended to gain new biological insights in to melanoma development or progression.
- Translational Research Grants: These grants are intended to fund clinically important melanoma research.
Deadline: Feb 01, 2012
For more info: http://www.hjltrust.org/grants.html
The Myocarditis Foundation (MF) awards funds to support research related to all forms of myocarditis. The goal of MF's research program is to advance medical knowledge on the disease and develop more accurate diagnostic methods and life-improving therapies with the goal of saving more lives.
MF accepts fellowship grant applications on an annual basis for innovative basic, clinical or translational research relevant to the cause or treatment of myocarditis. MF's fellowship grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting preliminary data to help secure long-term funding by the National Institute of Health (NIH) and other major granting institutions. Research may involve human subjects and animal subjects.
Candidates may apply up to 10 years following receipt of an M.D., Ph.D., or an equivalent degree and plan to perform the funded work in the United States or Canada, in order to apply for the Fellowship.
Amount: $35,000 for one year
Deadline: Dec 01, 2011
For more info: http://myocarditisfoundation.org/research/
Parkinson's and Movement Disorder Foundation
The Parkinson's and Movement Disorder Foundation (PMDF) is awarding 2 small grants of $5000 each for research into any aspect of Parkinson's disease or other movement disorders, particularly dystonias. We are especially interested in funding basic or clinical research into the causes of or treatments for these disorders, but will entertain other research ideas.
Deadline: Oct 21, 2011
For more info: http://www.pmdf.org/
SmartTots - Research on Whether Neonatal and Early Childhood Anesthetic Exposure in Humans Impairs Brain Development
SmartTots is accepting applications aimed at investigating whether anesthetics/sedatives are neurotoxic and/or impede the normal development of the human brain. Projects eligible for funding through this Request for Applications should focus on whether neonatal and early childhood anesthetic exposure in humans impairs brain development resulting in persistent detrimental effects on cognition or behavior. Retrospective or prospective studies in any species will be considered, provided they inform the existence of anesthetic-induced developmental neurotoxicity in humans. Specific questions of interest include:
- Do short and/or long anesthetic exposures in human neonates and young children result in neuronal or glial cell death, structural abnormalities of the brain or functional abnormalities of the brain?
- Do short and/or long anesthetic exposures in human neonates and young children result in persistent behavioral abnormalities (intellectual, motor, social, emotional etc)?
- Are specific anesthetics and sedatives or specific frequency, duration or timing of anesthetic exposure correlated with detrimental effects on brain structure or function in humans?
Deadline: Oct 21, 2011.
For more info: http://www.smarttots.org/RFA.html
Stem Cell Network - Transitional Research Grant
The SCN's Transitional Research Grant program provides financial support to SCN postdoctoral fellows or research associates to manage/undertake a research project while under the supervision of a SCN principal investigator. The purpose of this program is to promote retention of SCN trainees in the field of stem cell research and in Canada; to promote research excellence among senior trainees; and to promote networking and among trainees and PIs.
Candidates must be postdoctoral fellows with a minimum of one year of PDF experience at the time of application, or research associates and working in the stem cell field under the supervision of a SCN principal investigator. Candidates must have worked for a minimum of two years in the stem cell field prior to applying for the award and must intend to pursue research directly related to this area.
Amount: up to $20,000 per year for a maximum of two years
Deadline: Feb 01, 2012
For more info: http://29939.vws.magma.ca/index.php?page=transitional-research-grant&hl=eng
U.S. Army Medical Research and Materiel Command
Current programs include:
• Military Infectious Diseases Research Program
• Combat Casualty Care Research Program
• Military Operational Medicine Research Program
• Clinical and Rehabilitative Medicine Research Program
• Medical Biological Defense Research Program
• Medical Chemical Defense Research Program
• Telemedicine and Advanced Technology Program
For more info: https://www.usamraa.army.mil/pages/baa_forms/index.cfm
US Dept of Defense - Defense Medical Research and Development Program
Current programs include:
• Psychological Health/Traumatic Brain Injury Applied Neurotrauma Research Award
For more info: http://cdmrp.army.mil/funding/pa/11phtbianra_pa.pdf
Attached Files
Social Media
Accessibility at Western
